WO2023200286A1 - Medicinal liquid injection device - Google Patents

Medicinal liquid injection device Download PDF

Info

Publication number
WO2023200286A1
WO2023200286A1 PCT/KR2023/005059 KR2023005059W WO2023200286A1 WO 2023200286 A1 WO2023200286 A1 WO 2023200286A1 KR 2023005059 W KR2023005059 W KR 2023005059W WO 2023200286 A1 WO2023200286 A1 WO 2023200286A1
Authority
WO
WIPO (PCT)
Prior art keywords
unit
chemical solution
pressure generator
chemical
pressure
Prior art date
Application number
PCT/KR2023/005059
Other languages
French (fr)
Korean (ko)
Inventor
쥐 웰스포드이안
네프제임스
플린트니브
Original Assignee
이오플로우㈜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이오플로우㈜ filed Critical 이오플로우㈜
Priority to KR1020237021654A priority Critical patent/KR20230148323A/en
Publication of WO2023200286A1 publication Critical patent/WO2023200286A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877Adjusting flow; Devices for setting a flow rate
    • A61M5/16881Regulating valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16886Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate

Definitions

  • the present invention relates to a chemical injection device.
  • a drug injection device such as an insulin injection device is used to inject a drug solution into a patient's body.
  • chemical injection devices are sometimes used by professional medical staff such as doctors and nurses, but in most cases, they are used by the general public, such as patients themselves or their guardians.
  • a patch-type drug injection device that is attached to the human body for a certain period of time is being developed, and this drug injection device can be used while attached to the patient's body, such as the abdomen or waist, in the form of a patch for a certain period of time.
  • the drug injection device In order to increase the effect through drug injection, the drug injection device needs to be controlled to precisely inject the drug into the patient's body. It is important to precisely inject a small amount of drug solution through a small drug injection device.
  • a chemical injection device When attached to the human body, a chemical injection device needs to be comfortable to wear, convenient to use, durable, and run at low power.
  • the drug injection device is used by attaching it directly to the patient's skin, it is important for the user to conveniently and safely operate the drug injection device.
  • the present invention provides a chemical injection device in which the pressure generator generates pressure by the flow of fluid and the chemical liquid can be stably supplied to the needle assembly, thereby improving user convenience.
  • One aspect of the present invention includes a reservoir unit containing a chemical solution; a pressure generator connected to the reservoir unit and providing a flow path for the chemical solution supplied from the reservoir unit; and a needle assembly capable of receiving the chemical solution from the pressure generator and discharging it to the outside, wherein the pressure generator increases the pressure of the chemical solution while the chemical solution flows in a preset direction.
  • a device containing a chemical solution
  • a pressure generator connected to the reservoir unit and providing a flow path for the chemical solution supplied from the reservoir unit
  • a needle assembly capable of receiving the chemical solution from the pressure generator and discharging it to the outside, wherein the pressure generator increases the pressure of the chemical solution while the chemical solution flows in a preset direction.
  • it may further include a valve portion disposed between the pressure generator and the needle assembly and supplying a preset amount of chemical solution to the needle assembly.
  • it may further include a sensor unit connected to the valve unit and sensing the flow rate of the chemical solution flowing into the valve unit.
  • control unit that is electrically connected to the sensor unit and receives information about the flow rate of the chemical solution from the sensor unit to control the operation of the pressure generator.
  • it may further include a power supply unit that is electrically connected to the pressure generator and supplies power to the pressure generator to form an electric field.
  • it may further include a base portion on which the reservoir unit, the pressure generating portion, and the needle assembly are installed.
  • the needle assembly may include a needle portion that penetrates the base portion and is exposed to the outside.
  • the pressure generator receives voltage and generates pressure by the flow of fluid, and the chemical liquid can be stably supplied to the needle assembly, providing convenience to the user. It works.
  • a preset amount of chemical solution is supplied to the needle assembly, which has the effect of precisely controlling the amount of chemical solution injected into the user.
  • FIG. 1 is a block diagram showing a chemical injection system according to an embodiment of the present invention.
  • Figure 2 is a block diagram showing a chemical injection device according to an embodiment of the present invention.
  • Figure 3 is a perspective view partially showing a chemical injection device according to an embodiment of the present invention.
  • Figure 4 is a side cross-sectional view showing part A of Figure 3.
  • Figure 5 is a plan view showing a pressure generator according to an embodiment of the present invention.
  • Figure 6 is an enlarged view showing part B of Figure 5.
  • Figure 7 is a perspective view showing a pressure generator according to another embodiment of the present invention.
  • Figure 8 is a diagram schematically showing a valve unit according to an embodiment of the present invention.
  • Figure 9 is a block diagram showing a sensor unit, a control unit, etc. according to an embodiment of the present invention.
  • FIG. 10 is a diagram showing the state in which the chemical solution flows in FIG. 8.
  • a specific process sequence may be performed differently from the described sequence.
  • two processes described in succession may be performed substantially at the same time, or may be performed in an order opposite to that in which they are described.
  • Figure 1 is a block diagram showing a chemical injection system 1 according to an embodiment of the present invention.
  • the drug injection system 1 may include a drug injection device 10, a user terminal 20, a controller 30, and a biometric information sensor 40.
  • the drug injection system 1 allows the user to drive and control the system using the user terminal 20, and the drug injection device 10 injects the drug based on the blood sugar information monitored by the biometric information sensor 40. It can be injected periodically.
  • the drug injection device 10 injects drugs to be injected into the user, such as insulin, glucagon, anesthetics, painkillers, dopamine, growth hormone, and smoking cessation aids, based on data sensed by the biometric information sensor 40. It also performs a function.
  • drugs to be injected into the user such as insulin, glucagon, anesthetics, painkillers, dopamine, growth hormone, and smoking cessation aids, based on data sensed by the biometric information sensor 40. It also performs a function.
  • the chemical injection device 10 may transmit a device status message including information on the device's remaining battery capacity, whether the device was successfully booted, whether the injection was successful, etc., to the controller 30 .
  • Messages delivered to the controller may be delivered to the user terminal 20 through the controller 30.
  • the controller 30 may transmit improved data processed from the received messages to the user terminal 20.
  • the chemical injection device 10 is provided separately from the biometric information sensor 40 and may be installed to be spaced apart from the object. In another embodiment, the drug injection device 10 and the biometric information sensor 40 may be provided in one device.
  • the drug injection device 10 may be mounted on the user's body. Additionally, in another embodiment, the chemical injection device 10 can be mounted on an animal to inject the chemical solution.
  • the user terminal 20 may receive an input signal from the user to drive and control the chemical injection system 1.
  • the user terminal 20 may generate a signal that drives the controller 30 and control the controller 30 to drive the chemical injection device 10.
  • the user terminal 20 can display biometric information measured from the biometric information sensor 40 and status information of the chemical injection device 10 .
  • the user terminal 20 refers to a communication terminal that can be used in a wired or wireless communication environment.
  • the user terminal 20 includes a smartphone, a tablet PC, a PC, a smart TV, a mobile phone, a personal digital assistant (PDA), a laptop, a media player, a micro server, a global positioning system (GPS) device, an e-book terminal, It may be a digital broadcasting terminal, navigation, kiosk, MP3 player, digital camera, home appliance, camera-equipped device, and other mobile or non-mobile computing devices.
  • PDA personal digital assistant
  • GPS global positioning system
  • e-book terminal It may be a digital broadcasting terminal, navigation, kiosk, MP3 player, digital camera, home appliance, camera-equipped device, and other mobile or non-mobile computing devices.
  • the user terminal 20 may be a wearable device such as a watch, glasses, hair band, or ring equipped with a communication function and data processing function.
  • a wearable device such as a watch, glasses, hair band, or ring equipped with a communication function and data processing function.
  • terminals equipped with applications capable of Internet communication can be borrowed without limitation.
  • the user terminal 20 can be connected one-to-one with the pre-registered controller 30.
  • the user terminal 20 may be encrypted and connected to the controller 30 in order to prevent the controller 30 from being driven and controlled by an external device.
  • the user terminal 20 and the controller 30 may be separated and provided as separate devices.
  • the controller 30 may be provided to a subject equipped with the chemical injection device 10, and the user terminal 20 may be provided to the subject or a third party.
  • the user terminal 20 is driven by the guardian, thereby improving the safety of the chemical injection system 1.
  • the user terminal 20 and the controller 30 may be provided as one device.
  • the controller 30, which is provided as one with the user terminal 20, can communicate with the drug injection device 10 to control the injection of the drug.
  • the controller 30 performs a function of transmitting and receiving data with the drug injection device 10, transmits a control signal related to the injection of drugs such as insulin to the drug injection device 10, and detects blood sugar levels from the biometric information sensor 40. Control signals related to measurement of biometric values, such as the like, can be received.
  • the controller 30 may transmit an instruction request to measure the user's current state to the chemical injection device 10 and receive measurement data from the chemical injection device 10 in response to the instruction request.
  • the biometric information sensor 40 may perform a function of measuring the user's biometric values such as blood sugar level, blood pressure, and heart rate depending on the purpose. Data measured by the biometric sensor 40 may be transmitted to the controller 30, and the injection cycle or injection amount of the drug may be set based on the measured data. Data measured by the biometric information sensor 40 may be transmitted to the user terminal 20 and displayed.
  • the biometric information sensor 40 may be a sensor that measures the blood sugar level of the subject. It may be a continuous glucose monitoring (CGM) sensor. A continuous blood sugar measurement sensor can be attached to an object and continuously monitor blood sugar level.
  • CGM continuous glucose monitoring
  • the user terminal 20, the controller 30, and the chemical injection device 10 may communicate using a network.
  • networks include Local Area Network (LAN), Wide Area Network (WAN), Value Added Network (VAN), mobile radio communication network, satellite communication network, and their It is a comprehensive data communication network that includes mutual combinations and allows each network member to communicate smoothly with each other, and may include wired Internet, wireless Internet, and mobile wireless communication networks.
  • LAN Local Area Network
  • WAN Wide Area Network
  • VAN Value Added Network
  • mobile radio communication network satellite communication network
  • satellite communication network and their It is a comprehensive data communication network that includes mutual combinations and allows each network member to communicate smoothly with each other, and may include wired Internet, wireless Internet, and mobile wireless communication networks.
  • wireless communications include, for example, wireless LAN (Wi-Fi), Bluetooth, Bluetooth low energy, ZigBee, WFD (Wi-Fi Direct), UWB (ultra wideband), and infrared communications (IrDA). Data Association), NFC (Near Field Communication), 5G, etc., but are not limited to these.
  • Figure 2 is a block diagram showing a chemical injection device according to an embodiment of the present invention.
  • Figure 3 is a perspective view partially showing a chemical injection device according to an embodiment of the present invention.
  • Figure 4 is a side cross-sectional view showing part A of Figure 3.
  • Figure 5 is a plan view showing a pressure generator according to an embodiment of the present invention.
  • Figure 6 is an enlarged view showing part B of Figure 5.
  • Figure 8 is a diagram schematically showing a valve unit according to an embodiment of the present invention.
  • Figure 9 is a block diagram showing a sensor unit, a control unit, etc. according to an embodiment of the present invention.
  • FIG. 10 is a diagram showing the state in which the chemical solution flows in FIG. 8.
  • the chemical injection device 10 is attached to the body (HB) of the user to inject the chemical liquid (D), and contains the chemical liquid (D) stored therein.
  • D) can be injected to the user at a preset cycle or in a preset amount.
  • the chemical injection device 10 can be used for various purposes depending on the type of chemical solution D to be injected.
  • the drug solution D may include an insulin-based drug solution for diabetic patients, a drug solution for the pancreas, a drug solution for the heart, and other various types of drug solutions.
  • the chemical injection device 10 includes a base portion 100, a reservoir unit 200, a substrate portion 300, and a pressure generator. It may include (400), a valve unit (500), a needle assembly (600), a power unit (700), a sensor unit (810), and a control unit (850).
  • the base portion 100 may include a base body 110 and a sealing member 130.
  • the base body 110 forms the exterior of the chemical injection device 10 and includes a reservoir unit 200, a substrate portion 300, a pressure generator 400, which will be described later,
  • the valve unit 500, needle assembly 600, power unit 700, sensor unit 810, and control unit 850 may be installed, and the interior may be hollow.
  • One side of the base body 110 (lower surface in FIG. 3) is attachable to the body (HB) of a user such as a patient who is to be injected with the drug solution (D) through the drug injection device 10, and has an adhesive member (not shown). ) can be applied.
  • the adhesive member may be covered by a separate cover (not shown), in the case where it is desired to attach the chemical injection device 10, specifically the base body 110, to the user's body (HB).
  • the cover covering the adhesive member can be removed.
  • the adhesive member exerts adhesive force and has the effect of maintaining the chemical injection device 10, specifically the base body 110, attached to the user's body.
  • the base body 110 is formed in a disk shape, but is not limited to this, and the side wall extends along the circumferential direction based on the center of the base body 110, and the inner space formed by the side wall is formed.
  • a reservoir unit 200, a substrate unit 300, a pressure generator 400, a valve unit 500, a needle assembly 600, a power unit 700, a sensor unit 810, and a control unit 850 are disposed.
  • Various modifications are possible, such as:
  • the base body 110 may be formed in a polygonal shape, such as a square plate shape.
  • the chemical injection device 10 specifically the base portion 100, includes a base body 110, a reservoir unit 200 disposed on the base body 110, a substrate portion 300, It may include a cover part (not shown) covering the pressure generating unit 400, valve unit 500, needle assembly 600, power unit 700, sensor unit 810, and control unit 850.
  • a cover part not shown covering the pressure generating unit 400, valve unit 500, needle assembly 600, power unit 700, sensor unit 810, and control unit 850.
  • the cover portion covers the base body 110 and is connected to the base body 110, thereby preventing foreign substances from entering the chemical injection device 10 from the outside.
  • a needle assembly 600 which will be described later, may be connected to the base body 110 according to an embodiment of the present invention.
  • the needle assembly 600 may include a cannula (CN) and a needle portion (ND), and the needle portion (ND) may move within the cannula (CN) along a preset direction.
  • the needle part (ND) passes through the base body 110 and moves outward, it can contact and penetrate the user's body and inject the chemical solution (D) into the user, and when use is completed, in the opposite direction.
  • the needle part ND may move and leave the user's body.
  • An opening may be formed at the outer end of the needle portion (ND) according to an embodiment of the present invention, and the medical solution (D) may be injected into the user's body (HB) through the opening.
  • the cannula (CN) and the needle portion (ND) may be connected and formed as one piece.
  • the material of the cannula (CN) and the material of the needle portion (ND) may be formed differently.
  • the base body 110 may be formed with an insertion hole 110h through which the needle assembly 600, specifically the cannula CN through which the needle portion ND can move on the inside, can pass,
  • a sealing member 130 may be disposed in the insertion hole portion 110h.
  • the sealing member 130 may be formed of a material capable of elastic deformation, and may have a hole (reference numeral not set) through which the needle assembly 600, specifically the cannula CN, can penetrate and contact the sealing member 130. can be formed.
  • the sealing member 130 is disposed between the base body 110 and the cannula (CN) and is made of an elastically deformable material, the inner peripheral surface of the insertion hole portion 110h formed in the base body 110 and the cannula (CN) ) can seal the gap formed between them, and prevent the chemical solution (D) injected into the user's body (HB) from passing through the chemical injection device 10 and the base body 110 and flowing into the internal space. There is a possible effect.
  • the reservoir unit 200 accommodates the chemical solution (D), and is installed in the base portion 100, specifically the base body 110. It is placed and may be connected to the needle assembly 600.
  • the chemical liquid (D) can be stored in the internal space of the reservoir unit 200, and the interior is hollow, and the chemical liquid (D) can be supplied to the pressure generator 400 through the supply pipe 201 formed in a tube shape. there is.
  • the chemical solution (D) may be injected into the reservoir unit 200 through a separate external device (not shown).
  • a supply pipe 201 having a hollow interior may be extended on one side of the reservoir unit 200, and the internal space of the reservoir unit 200 may be communicated with the external space.
  • the supply pipe 201 formed in the reservoir unit 200 is connected to the pressure generator 400, which will be described later, and as pressure is generated in the pressure generator 400, the chemical liquid ( D) may flow in a preset direction, that is, in the direction of injection from the reservoir unit 200 through the needle assembly 600 into the user's body (HB).
  • the chemical liquid (D) from the reservoir unit 200 can additionally flow into the pressure generator 400 through the supply pipe 201, and the pressure of the chemical liquid (D) flowing in the pressure generator 400 is increased.
  • This has the effect of supplying the chemical solution (D) to the valve unit 500 and needle assembly 600, which will be explained later.
  • the substrate portion 300 is installed on the base portion 100, specifically the base body 110, and includes a pressure generating portion 400 and a needle assembly 600. ) and the power supply unit 700 are electrically connected, an electrical path can be provided.
  • the substrate 300 may be a printed circuit board (PCB).
  • PCB printed circuit board
  • the power supply unit 700 is disposed between the substrate unit 300 and one surface of the base body 110 (bottom surface based on FIG. 3), and is electrically connected to the pressure generating unit 400 and the needle assembly 600. It can be connected, and voltage can be applied to the pressure generator 400 and the needle assembly 600.
  • the substrate portion 300 has a needle assembly 600, specifically a hole portion (drawing) so that a cannula (CN) within which the needle portion (ND) can move can pass. (sign not set) may be formed.
  • the needle assembly 600 specifically the cannula CN, passes through the area where the substrate 300 is not disposed in the inner space of the base body 110, and then passes through the insertion hole formed in the base body 110.
  • Various modifications are possible, such as passing (110h).
  • the needle portion (ND) may not move along a preset direction inside the cannula (CN), but the needle portion (ND) and the cannula (CN) may be connected and formed as one body.
  • the cannula (CN) and the needle portion (ND) may be formed of different materials, and the stiffness of the needle portion (ND) may be relatively greater than that of the cannula (CN).
  • a control unit 850 may be disposed on the substrate unit 300, and the control unit 850 is electrically connected to the pressure generator 400, and provides information on the flow rate of the chemical solution (D) from the sensor unit 810, which will be described later. By receiving information and transmitting an electrical signal to the pressure generator 400, the operation of the pressure generator 400 can be controlled.
  • control unit 850 may be electrically connected to the sensor unit 810, which will be explained later, and receives information about the flow rate of the chemical solution (D) from the sensor unit 810 to the pressure generator 400, which will be explained later.
  • the operation of the pressure generator 400 can be controlled by transmitting an electrical signal.
  • the pressure generating unit 400 according to an embodiment of the present invention is connected to the reservoir unit 200, and the reservoir unit 200 and the valve unit It can be placed between (500).
  • the pressure generator 400 can provide a flow path for the chemical liquid (D) supplied from the reservoir unit 200, and the chemical liquid (D) flows along a preset direction. It has the effect of increasing the pressure of the chemical solution (D).
  • the pressure of the chemical liquid (D) increased by the pressure generator 400 may be transmitted to the valve unit 500, which will be described later, and the chemical liquid (D) having the pressure may be transmitted to the valve unit. It is delivered to 500, and when a preset flow rate flows into the valve unit 500, it can be injected from the valve unit 500 into the user's body (HB) through the needle assembly 600.
  • the pressure generator 400 may include a pressure generator body 410 and an electrode portion 430.
  • the pressure generating body 410 is disposed inside the base body 110 and may be coupled to the substrate portion 300.
  • the pressure generating body 410 may have a fastening hole 411 formed in the shape of a hole, and a protrusion 301 formed on the substrate 300 may have a fastening hole 411. You can pass. This has the effect of stably fixing the position of the pressure generating body 410 on the substrate 300.
  • a plurality of fastening hole portions 411 formed in the pressure generating body 410 may be provided, and may be arranged symmetrically with respect to the origin with respect to the center of the pressure generating body 410.
  • the pressure generating body 410 By being connected to the substrate portion 300 at a plurality of points based on the center of the pressure generating body 410, the pressure generating body 410 can be prevented from shaking on the substrate portion 300 and can be stably fixed in position. You can.
  • an inlet hole portion 412 and an discharge hole portion 413 may be formed in the pressure generating body 410 according to an embodiment of the present invention, respectively.
  • the inlet hole portion 412 is in communication with the supply pipe 201 formed in the reservoir unit 200, and the chemical solution (D) can flow into the pressure generating body 410 through the inlet hole portion 412.
  • the discharge hole portion 413 formed in the pressure generating body 410 is in communication with the valve portion 500, which will be described later, and passes through the flow path formed in the pressure generating main body 410.
  • the chemical solution (D) is discharged and may flow into the valve unit 500.
  • a first flow path portion 414 and a second flow path portion 415 may be formed in the pressure generating body 410 according to an embodiment of the present invention.
  • the first passage portion 414 and the second passage portion 415 communicate with the inlet hole portion 412 and the discharge hole portion 413 formed in the pressure generating body 410, and the inlet hole portion 412 and the discharge hole portion 413 ) can be formed between.
  • the first flow path portion 414 and the second flow path portion 415 may be in communication, and may each be provided in plural numbers.
  • the first flow path portion 414 and the second flow path portion 415 may be arranged to sequentially communicate with each other.
  • the first flow path portion 414 forms a flow path for the chemical solution (D) flowing into the pressure generating body 410 through the inlet hole portion 412, and may be provided in plural pieces. there is.
  • the first passage portion 414 extends along a preset direction (up and down direction based on FIG. 6), and a plurality of first passage portions 414 may be arranged side by side.
  • a partition wall 416 may be disposed between the plurality of first flow passage parts 414.
  • the cross-sectional area of the first passage portion 414 formed in the pressure generating body 410 is relatively smaller than the cross-sectional area of the second passage portion 415 communicating with the first passage portion 414. can be formed.
  • a plurality of first passage portions 414 may be provided, and the sum of the cross-sectional areas of the plurality of first passage portions 414 may be formed as a single It may be formed to be larger than the cross-sectional area of the second flow path portion 415.
  • electrode portions 430 having different polarities specifically a first electrode 430a and a second electrode 430b. Each of these can be arranged.
  • an electric field EF may be formed on the first passage unit 414 and is accommodated in the first passage unit 414.
  • the chemical solution D may flow in the direction of the electric field EF, that is, from the first electrode 430a to the second electrode 430b.
  • the first electrode 430a and the second electrode 430b may have different polarities.
  • the first electrode 430a may be formed as a positive electrode
  • the second electrode 430b may be formed as a negative electrode.
  • the electrode unit 430 Before the electrode unit 430 according to an embodiment of the present invention receives voltage from the power supply unit 700, the chemical solution (D) contained in the pressure generator 400 does not move, and the electrode unit 430 applies the voltage. As the applied electric field (EF) is formed, the chemical solution (D) accommodated in the first flow path portion 414 has a preset speed, and pressure can be generated accordingly.
  • EF applied electric field
  • the second flow path portion 415 formed in the pressure generating unit 400 is in communication with the first flow path portion 414 and can provide a flow path for the chemical solution D.
  • a plurality of second flow passage parts 415 may be provided, and a plurality of second flow passage parts 415 may be disposed at the inlet end and the discharge end of the first flow passage part 414, respectively.
  • the chemical solution (D) contained in the second flow path portion 415 is, like the first flow path portion 414, an electrode portion 430 that receives a voltage from the power supply portion 700, specifically the first flow path portion 414.
  • the chemical solution (D) does not flow due to the electric field (EF) formed by the electrode 430a and the second electrode 430b, but moves to the first flow path portion of the next step due to the pressure generated in the first flow path portion 414.
  • the chemical solution (D) can flow up to (414).
  • first passage portions 414 and second passage portions 415 according to an embodiment of the present invention are provided, and the first passage portion 414 on which electrode portions 430 are disposed on both sides
  • the process by which the passed chemical solution (D) enters the second flow path portion 415 can be defined as a 'single step'.
  • the plurality of first passage portions 414, second passage portions 415, and electrode portions 430 are sequentially arranged, and a plurality of single steps are connected to form ‘multiple steps’. there is.
  • Pressure can be generated in the chemical solution (D) while passing through the first passage portion 414 formed in a single stage, and passing through the second passage portion 415 again provided in another single stage ( 414), the pressure may increase.
  • the pressure generator 400 has the effect of generating a target pressure depending on how many single steps a multiple step consists of.
  • the sum of the cross-sectional areas of the plurality of first passage portions 414 may be relatively larger than the cross-sectional area of the second passage portions 415.
  • the flow rate of the chemical solution (D) in the second flow path portion 415 increases compared to the flow rate of the chemical solution (D) passing through the plurality of first flow path portions 414, and the first flow path portion 415 increases.
  • the chemical solution (D) may flow on the second flow path portion 415 due to the pressure generated while passing through the portion 414.
  • the pressure generated in the pressure generator 400 can be transmitted to the valve portion 500, which will be explained later, and the chemical solution (D) discharged from the pressure generator 400 is connected to the valve portion 500 and the needle assembly 600. It can be injected into the user's body (HB).
  • the flow directions of the chemical solution D within the first flow path portion 414 and the second flow path portion 415 may be formed differently. Specifically, the flow direction of the chemical liquid within the first flow path portion 414 and the second flow path portion 415 may be formed in opposite directions.
  • a plurality of single stages can be arranged in parallel with each other, and the volume occupied by the pressure generator 400 inside the base body 110 can be reduced compared to a case where a plurality of single stages are arranged in series.
  • the electrode unit 430 when the electrode unit 430 receives voltage in a state in which no flow of the chemical solution (D) occurs, the chemical solution (D) flows due to the generated electric field (EF) and a speed is generated. do.
  • the chemical solution follows the direction of the electric field (EF) formed by the electrode portion 430 disposed in the step. (D) flows, and the flow speed of the chemical solution (D) can increase, which has the effect of increasing the pressure.
  • EF electric field
  • the chemical solution (D) that has gone through a plurality of single stages is discharged to the outside of the pressure generator 400 through the discharge hole portion 413 in communication with the first flow path portion 414 or the second flow path portion 415.
  • the electrode unit 430 according to an embodiment of the present invention is disposed in the pressure generating body 410, and the placement hole portion (reference numeral not set) is formed in the pressure generating main body 410. ) can be inserted.
  • the electrode unit 430 includes a plurality of electrodes, specifically a first electrode 430a and a second electrode 430b, and the first electrode 430a and the second electrode 430b are connected to each other. Can have different polarities.
  • the first electrode 430a may be formed as an anode
  • the second electrode 430b may be formed as a cathode.
  • the electrode portion 430 may be disposed on both sides of the first passage portion 414, and the chemical solution D flows therein.
  • the first electrode 430a may be disposed on the side of the area where the chemical solution D is discharged through the first passage portion 414
  • the second electrode 430b may be disposed on the side of the area where the chemical solution D is discharged through the first flow path 414.
  • the electrode unit 430 may be electrically connected to the power supply unit 700 and may receive voltage from the power supply unit 700 to form an electric field EF.
  • the electric field (EF) is formed between the first electrode (430a) and the second electrode (430b)
  • the chemical solution (D) is preset along the first passage portion 414 that overlaps the electric field (EF).
  • FIG 7 is a perspective view showing the pressure generator 400' according to another embodiment of the present invention.
  • the pressure generating unit 400' may include a pressure generating body 410' and an electrode unit 430'.
  • the electrode portion 430 ⁇ may include a first electrode 430 ⁇ a and a second electrode 430 ⁇ b, and may be provided in plural pieces.
  • the pressure generator 400' includes electrode parts 430' disposed on both sides of the first flow path part 414', specifically the first electrode 430'a and the second electrode. Except that (430'b) is each disposed as a single electrode, the configuration, operating principle, and effect of increasing the pressure as the chemical solution (D) flowing through the pressure generator (400') flows are the same as those of the present invention. Since it is the same as the pressure generating unit 400 according to one embodiment, detailed description will be omitted to the extent of overlap.
  • valve unit 500 according to an embodiment of the present invention is disposed between the pressure generating unit 400 and the needle assembly 600, and is preset. A sufficient amount of chemical solution (D) can be supplied to the needle assembly 600.
  • the valve unit 500 may include a valve body 510 and a deformation unit 530.
  • the valve body 510 provides a flow path so that the chemical solution (D) flowing in from the pressure generator 400 can flow, and a first valve flow path 511 and a second valve flow path 513 can be formed. .
  • first valve passage 511 is connected to the pressure generator 400 and provides an inflow path for the chemical liquid (D)
  • second valve passage 513 is connected to the needle assembly 600 and provides an inflow path for the chemical liquid (D).
  • the purpose is to provide an emission route for .
  • the first valve passage 511 and the second valve passage 513 have a hollow interior and may be formed in a tube shape.
  • Chemical liquid (D) with pressure can flow from the pressure generator 400 through the first valve passage 511 and the second valve passage 513, and can be smoothly supplied back to the needle assembly 600. It works.
  • the deformable portion 530 is connected to the valve body 510, and can form a chemical liquid (D) receiving space (DS) together with the valve body 510. there is.
  • the chemical liquid (D) accommodating space refers to an internal space surrounded by one side of the valve body 510 facing the deformable part 530 and the inner peripheral surface of the deformable part 530, and the chemical liquid (D) This can be accepted.
  • the volume of the chemical liquid (D) receiving space (DS) changes, and the volume of the chemical liquid (D) receiving space (DS), that is, the amount of chemical liquid (D), is preset.
  • the chemical solution (D) can be supplied to the needle assembly 600 through the second valve passage 513 by the pressure generated from the pressure generator 400.
  • volume (V) that can be accommodated in the chemical solution (D) accommodation space (DS) can be derived through the following process.
  • the volume (V) of the chemical solution (D) receiving space (DS) is as follows.
  • volume (V) of the chemical solution (D) that can be accommodated in the chemical solution (D) receiving space (DS) is as follows.
  • E is the elastic modulus
  • v is the Poisson ratio
  • h is the thickness of the deformed part 530
  • r is the distance from the center of the deformed part 530
  • P is pressure generation.
  • the pressure received from the unit 400 and applied to the valve unit 500, specifically the deformable part 530, a denotes the radius of the deformed part 530.
  • the volume of the chemical liquid (D) in the chemical liquid (D) receiving space (DS) may be defined as a function of the pressure transmitted from the pressure generator 400, and is deformed when a preset volume is reached. Because the shape of the portion 530 is modified to move toward the valve body 510, the chemical solution D can be effectively delivered to the needle assembly 600.
  • the chemical solution (D) at a preset cycle and a fixed amount must be injected into the user's body through the chemical injection device 10, and the pressure generated by the pressure generator 400 is used to inject the drug solution (D) into the user's body.
  • the amount of the drug solution (D) accommodated in the drug solution (D) receiving space (DS) reaches a preset amount, the drug solution (D) will be stably and repeatedly delivered to the user's body through the needle assembly 600. There is a possible effect.
  • the needle assembly 600 is capable of receiving the chemical solution (D) from the pressure generating unit 400 and discharging it to the outside, and includes a cannula (CN) and a needle unit (ND). , may include a shaft portion 610, an insertion portion 630, and an extraction portion.
  • the needle assembly 600 provides a flow path for the chemical solution (D) delivered from the valve unit 500, and the needle unit (ND) located inside the cannula (CN) contacts the user's body (HB).
  • the chemical solution (D) can be injected into the body.
  • the insertion unit 630 and the extraction unit can be relatively rotated based on the longitudinal central axis of the shaft unit 610, and the cannula (CN) and needle unit (ND) can be rotated relative to the user by their relative rotation. It can be contacted or inserted into the body, or extracted after use has been completed.
  • the insertion portion 630 includes a first elastic member 631 having an elastic restoring force in a first direction, and the extraction portion is aligned in the first direction with respect to the longitudinal central axis of the shaft portion 610. It may include a second elastic member 651 having elastic restoring force in a second direction, which is the opposite direction.
  • a priming step is taken to exhaust the air inside the cannula (CN) and needle part (ND) to the outside, which has the effect of injecting the drug solution (D) directly into the user's body.
  • the power supply unit 700 generates power and may be electrically connected to the pressure generating unit 400. Specifically, the power supply unit 700 may generate power and apply power to the electrode unit 430, thereby forming an electric field EF.
  • An electric field (EF) is formed between the electrode portions 430 disposed on both sides of the first flow path portion 414 formed in the pressure generating body 410, specifically the first electrode 430a and the second electrode 430b. Due to this, the fluid can flow in a preset direction and generate pressure, and this pressure generation process is a single step formed by the first flow path portion 414, the second flow path portion 415, and the electrode portion 430. There is an effect of generating a target pressure in the pressure generator 400 by going through the process multiple times.
  • the power supply unit 700 is electrically connected to the sensor unit 810, which will be described later, and can supply power to the sensor unit 810.
  • the sensor unit 810 is connected to the valve unit 500 and can sense the flow rate of the chemical solution (D) flowing into the valve unit 500. .
  • the sensor unit 810 can transmit information about the flow rate of the chemical solution (D) to the control unit 850 as an electrical signal, and the control unit 850 can control the operation of the pressure generator 400.
  • control unit 850 sends an electrical signal to the pressure generator 400 to generate the required pressure to reach the target volume of the chemical solution (D) receiving space (DS) of the valve unit 500. There is an effect of controlling the operation of the pressure generator 400 by transmitting.
  • the pressure generator receives voltage and generates pressure by the flow of fluid, and the chemical liquid can be stably supplied to the needle assembly, providing convenience to the user. It works.
  • a preset amount of chemical solution is supplied to the needle assembly, which has the effect of precisely controlling the amount of chemical solution injected into the user.
  • a chemical liquid injection device is provided. Additionally, embodiments of the present invention can be applied to industrial devices that inject medicinal solutions into a patient's body.

Abstract

An embodiment of the present invention provides a medicinal liquid injection device capable of improving user convenience, comprising: a reservoir unit in which medicinal liquid is accommodated; a pressure generating unit which is connected to the reservoir unit and provides a flow path for the medicinal liquid supplied from the reservoir unit; and a needle assembly which can receive the medicinal liquid from the pressure generating unit and discharge same to the outside, wherein the pressure generating unit increases the pressure of the medicinal liquid while the medicinal liquid flows in a preset direction, so that the medicinal liquid can be stably supplied to the needle assembly.

Description

약액 주입 장치chemical injection device
본 발명은 약액 주입 장치에 관한 것이다.The present invention relates to a chemical injection device.
일반적으로 인슐린 주입 장치와 같은 약액 주입 장치는 환자의 몸 안에 약액을 주입하기 위해 사용된다. 이러한 약액 주입 장치는 의사나 간호사와 같은 전문 의료진에 의해 사용되기도 하지만, 대부분의 경우 환자 자신 또는 보호자와 같은 일반인에 의해 사용되고 있다. Generally, a drug injection device such as an insulin injection device is used to inject a drug solution into a patient's body. These chemical injection devices are sometimes used by professional medical staff such as doctors and nurses, but in most cases, they are used by the general public, such as patients themselves or their guardians.
당뇨 환자 특히, 소아 당뇨 환자의 경우에는 인슐린과 같은 약액을 정해진 간격을 두고 인체에 주입할 필요가 있다. 일정한 기간 동안 인체에 부착하여 사용하는 패치 형태의 약액 주입 장치가 개발되고 있으며, 이러한 약액 주입 장치는 환자의 복부 또는 허리 등의 인체에 일정한 기간 동안 패치 형태로 부착한 상태로 사용될 수 있다.Diabetic patients, especially pediatric diabetic patients, need to inject medicinal solutions such as insulin into the body at set intervals. A patch-type drug injection device that is attached to the human body for a certain period of time is being developed, and this drug injection device can be used while attached to the patient's body, such as the abdomen or waist, in the form of a patch for a certain period of time.
약액 주입을 통한 효과의 증대를 위하여 약액 주입 장치는 약액을 환자의 몸에 정밀하게 주입하는 것이 제어될 필요가 있는데, 소형의 약액 주입 장치를 통하여 소량의 약액을 정밀하게 주입하는 것이 중요하다. In order to increase the effect through drug injection, the drug injection device needs to be controlled to precisely inject the drug into the patient's body. It is important to precisely inject a small amount of drug solution through a small drug injection device.
약액 주입 장치는 인체에 부착될 경우 착용감이 우수하고 사용이 편리하며 내구성이 뛰어나고 저전력으로 구동될 필요성이 있다. 특히, 약액 주입 장치는 환자가 직접 피부에 부착되어 사용되므로, 사용자가 편리하고 안전하게 약액 주입 장치를 구동하는 것이 중요하다.When attached to the human body, a chemical injection device needs to be comfortable to wear, convenient to use, durable, and run at low power. In particular, since the drug injection device is used by attaching it directly to the patient's skin, it is important for the user to conveniently and safely operate the drug injection device.
본 발명의 배경기술은 대한민국 등록특허공보 제10-2017-0106053호(2019.03.07. 등록, 발명의 명칭: 약액 주입 장치)에 개시되어 있다.The background technology of the present invention is disclosed in Republic of Korea Patent Publication No. 10-2017-0106053 (registered on March 7, 2019, title of invention: Chemical injection device).
종래 약액 주입 장치에는 정상작동이나 오작동을 사용자에게 알릴 수 있는 알람 기능이 있었으나, 정상작동 상태임에도 불구하고, 오류로 인하여 알람이 지속되며 사용자에게 불편함을 주는 문제점이 있었다.Conventional chemical injection devices had an alarm function that notified the user of normal operation or malfunction, but there was a problem in that the alarm continued due to an error even in normal operation, causing inconvenience to the user.
본 발명은 압력생성부가 유체의 유동에 의한 압력을 생성하고, 니들 어셈블리에 약액이 안정적으로 공급될 수 있어, 사용자의 사용 편의성을 향상시킬 수 있는 약액 주입 장치를 제공한다.The present invention provides a chemical injection device in which the pressure generator generates pressure by the flow of fluid and the chemical liquid can be stably supplied to the needle assembly, thereby improving user convenience.
본 발명의 일 측면은, 약액이 수용되는 레저버 유닛; 상기 레저버 유닛과 연결되고, 상기 레저버 유닛으로부터 공급되는 약액의 유동 경로를 제공하는 압력생성부; 및 상기 압력생성부로부터 약액을 공급받아 외부로 배출가능한 니들 어셈블리;를 포함하고, 상기 압력생성부는, 미리 설정되는 방향을 따라 약액이 유동하는 동안 상기 약액의 압력을 증가시키는 것을 특징으로 하는 약액 주입 장치를 제공한다.One aspect of the present invention includes a reservoir unit containing a chemical solution; a pressure generator connected to the reservoir unit and providing a flow path for the chemical solution supplied from the reservoir unit; and a needle assembly capable of receiving the chemical solution from the pressure generator and discharging it to the outside, wherein the pressure generator increases the pressure of the chemical solution while the chemical solution flows in a preset direction. Provides a device.
또한, 상기 압력생성부와 상기 니들 어셈블리 사이에 배치되며, 미리 설정되는 양만큼 약액을 상기 니들 어셈블리로 공급하는 밸브부;를 더 포함할 수 있다.In addition, it may further include a valve portion disposed between the pressure generator and the needle assembly and supplying a preset amount of chemical solution to the needle assembly.
또한, 상기 밸브부와 연결되고, 상기 밸브부로 유입되는 약액의 유량을 센싱하는 센서부;를 더 포함할 수 있다.In addition, it may further include a sensor unit connected to the valve unit and sensing the flow rate of the chemical solution flowing into the valve unit.
또한, 상기 센서부와 전기적으로 연결되고, 상기 센서부로부터 약액의 유량에 관한 정보를 전달받아 상기 압력생성부의 구동을 제어하는 제어부;를 더 포함할 수 있다.In addition, it may further include a control unit that is electrically connected to the sensor unit and receives information about the flow rate of the chemical solution from the sensor unit to control the operation of the pressure generator.
또한, 상기 압력생성부와 전기적으로 연결되고, 상기 압력생성부로 전원을 공급하여 전기장을 형성하는 전원부;를 더 포함할 수 있다.In addition, it may further include a power supply unit that is electrically connected to the pressure generator and supplies power to the pressure generator to form an electric field.
또한, 상기 레저버 유닛, 상기 압력생성부 및 상기 니들 어셈블리가 설치되는 베이스부;를 더 포함할 수 있다.In addition, it may further include a base portion on which the reservoir unit, the pressure generating portion, and the needle assembly are installed.
또한, 상기 니들 어셈블리는, 상기 베이스부를 관통하여 외부에 노출되는 니들부;를 포함할 수 있다.Additionally, the needle assembly may include a needle portion that penetrates the base portion and is exposed to the outside.
본 발명의 일 실시예에 따른 약액 주입 장치는, 압력생성부가 전압을 인가받아 유체의 유동에 의한 압력을 생성하고, 니들 어셈블리에 약액이 안정적으로 공급될 수 있어, 사용자에게 편의를 제공할 수 있는 효과가 있다.In the chemical injection device according to an embodiment of the present invention, the pressure generator receives voltage and generates pressure by the flow of fluid, and the chemical liquid can be stably supplied to the needle assembly, providing convenience to the user. It works.
또한, 형상 변형이 가능한 밸브부로 인하여, 미리 설정되는 양만큼 약액이 니들 어셈블리로 공급됨으로 인하여, 사용자에게 주입되는 약액의 양을 정밀하게 제어할 수 있는 효과가 있다.In addition, due to the valve part capable of changing shape, a preset amount of chemical solution is supplied to the needle assembly, which has the effect of precisely controlling the amount of chemical solution injected into the user.
물론 이러한 효과에 의해 본 발명의 범위가 한정되는 것은 아니다.Of course, the scope of the present invention is not limited by this effect.
도 1은 본 발명의 일 실시예에 따른 약액 주입 시스템을 도시하는 블록도이다.1 is a block diagram showing a chemical injection system according to an embodiment of the present invention.
도 2는 본 발명의 일 실시예에 따른 약액 주입 장치를 도시하는 블록도이다.Figure 2 is a block diagram showing a chemical injection device according to an embodiment of the present invention.
도 3은 본 발명의 일 실시예에 따른 약액 주입 장치를 부분적으로 도시한 사시도이다.Figure 3 is a perspective view partially showing a chemical injection device according to an embodiment of the present invention.
도 4는 도 3의 A부분을 도시한 측단면도이다.Figure 4 is a side cross-sectional view showing part A of Figure 3.
도 5는 본 발명의 일 실시예에 따른 압력생성부를 도시한 평면도이다.Figure 5 is a plan view showing a pressure generator according to an embodiment of the present invention.
도 6은 도 5의 B부분을 도시한 확대도이다.Figure 6 is an enlarged view showing part B of Figure 5.
도 7은 본 발명의 다른 실시예에 따른 압력생성부를 도시한 사시도이다.Figure 7 is a perspective view showing a pressure generator according to another embodiment of the present invention.
도 8은 본 발명의 일 실시예에 따른 밸브부를 개략적으로 도시한 도면이다.Figure 8 is a diagram schematically showing a valve unit according to an embodiment of the present invention.
도 9는 본 발명의 일 실시예에 따른 센서부, 제어부 등을 도시한 블록도이다.Figure 9 is a block diagram showing a sensor unit, a control unit, etc. according to an embodiment of the present invention.
도 10은 도 8에서 약액이 유동하는 상태를 도시한 도면이다.FIG. 10 is a diagram showing the state in which the chemical solution flows in FIG. 8.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 본 발명의 효과 및 특징, 그리고 그것들을 달성하는 방법은 도면과 함께 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 다양한 형태로 구현될 수 있다.Since the present invention can be modified in various ways and can have various embodiments, specific embodiments will be illustrated in the drawings and described in detail in the detailed description. The effects and features of the present invention and methods for achieving them will become clear by referring to the embodiments described in detail below along with the drawings. However, the present invention is not limited to the embodiments disclosed below and may be implemented in various forms.
이하, 첨부된 도면을 참조하여 본 발명의 실시예들을 상세히 설명하기로 하며, 도면을 참조하여 설명할 때 동일하거나 대응하는 구성 요소는 동일한 도면부호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다.Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings. When describing with reference to the drawings, identical or corresponding components will be assigned the same reference numerals and redundant description thereof will be omitted. .
이하의 실시예에서, 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.In the following examples, singular terms include plural terms unless the context clearly dictates otherwise.
이하의 실시예에서, 포함하다 또는 가지다 등의 용어는 명세서상에 기재된 특징, 또는 구성요소가 존재함을 의미하는 것이고, 하나 이상의 다른 특징들 또는 구성요소가 부가될 가능성을 미리 배제하는 것은 아니다.In the following embodiments, terms such as include or have mean that the features or components described in the specification exist, and do not exclude in advance the possibility of adding one or more other features or components.
어떤 실시예가 달리 구현 가능한 경우에 특정한 공정 순서는 설명되는 순서와 다르게 수행될 수도 있다. 예를 들어, 연속하여 설명되는 두 공정이 실질적으로 동시에 수행될 수도 있고, 설명되는 순서와 반대의 순서로 진행될 수 있다.In cases where an embodiment can be implemented differently, a specific process sequence may be performed differently from the described sequence. For example, two processes described in succession may be performed substantially at the same time, or may be performed in an order opposite to that in which they are described.
도면에서는 설명의 편의를 위하여 구성 요소들이 그 크기가 과장 또는 축소될 수 있다. 예컨대, 도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 임의로 나타내었으므로, 이하의 실시예는 반드시 도시된 바에 한정되지 않는다.In the drawings, the sizes of components may be exaggerated or reduced for convenience of explanation. For example, the size and thickness of each component shown in the drawings are arbitrarily shown for convenience of explanation, so the following embodiments are not necessarily limited to what is shown.
도 1은 본 발명의 일 실시예에 따른 약액 주입 시스템(1)을 도시하는 블록도이다.Figure 1 is a block diagram showing a chemical injection system 1 according to an embodiment of the present invention.
도 1을 참조하면, 약액 주입 시스템(1)은 약액 주입 장치(10), 사용자 단말(20), 컨트롤러(30) 및 생체 정보 센서(40)를 구비할 수 있다. 약액 주입 시스템(1)은 사용자 단말(20)을 이용하여 사용자가 시스템을 구동 및 제어할 수 있으며, 생체 정보 센서(40)에서 모니터링되는 혈당 정보를 기초로, 약액 주입 장치(10)에서 약액을 주기적으로 주입할 수 있다.Referring to FIG. 1 , the drug injection system 1 may include a drug injection device 10, a user terminal 20, a controller 30, and a biometric information sensor 40. The drug injection system 1 allows the user to drive and control the system using the user terminal 20, and the drug injection device 10 injects the drug based on the blood sugar information monitored by the biometric information sensor 40. It can be injected periodically.
약액 주입 장치(10)는 생체 정보 센서(40)에서 센싱된 데이터를 기초로, 사용자에게 주입되어야 하는 약물 예컨대, 인슐린, 글루카곤, 마취제, 진통제, 도파민, 성장 호르몬, 금연 보조제 등의 약물을 주입하는 기능을 수행하기도 한다.The drug injection device 10 injects drugs to be injected into the user, such as insulin, glucagon, anesthetics, painkillers, dopamine, growth hormone, and smoking cessation aids, based on data sensed by the biometric information sensor 40. It also performs a function.
또한, 약액 주입 장치(10)는 장치의 잔여 배터리 용량 정보, 장치의 부팅 성공 여부, 주입 성공 여부 등을 포함하는 장치 상태 메시지를 컨트롤러(30)에 전달할 수 있다. 컨트롤러로 전달된 메시지들은 컨트롤러(30)를 거쳐 사용자 단말(20)로 전달될 수 있다. 또는 컨트롤러(30)는 수신된 메시지들을 가공한 개량 데이터를 사용자 단말(20)로 전달할 수 있다. Additionally, the chemical injection device 10 may transmit a device status message including information on the device's remaining battery capacity, whether the device was successfully booted, whether the injection was successful, etc., to the controller 30 . Messages delivered to the controller may be delivered to the user terminal 20 through the controller 30. Alternatively, the controller 30 may transmit improved data processed from the received messages to the user terminal 20.
일 실시예로, 약액 주입 장치(10)는 생체 정보 센서(40)와 별도로 구비되며, 대상체에 이격되어 설치될 수 있다. 다른 실시예로, 약액 주입 장치(10)와 생체 정보 센서(40)는 하나의 디바이스에 구비될 수 있다.In one embodiment, the chemical injection device 10 is provided separately from the biometric information sensor 40 and may be installed to be spaced apart from the object. In another embodiment, the drug injection device 10 and the biometric information sensor 40 may be provided in one device.
일 실시예로, 약액 주입 장치(10)는 사용자의 몸에 장착될 수 있다. 또한 다른 실시예로 약액 주입 장치(10)는 동물에도 장착되어 약액을 주입할 수 있다. In one embodiment, the drug injection device 10 may be mounted on the user's body. Additionally, in another embodiment, the chemical injection device 10 can be mounted on an animal to inject the chemical solution.
사용자 단말(20)은 약액 주입 시스템(1)을 구동 및 제어하기 위해 사용자로부터 입력 신호를 입력 받을 수 있다. The user terminal 20 may receive an input signal from the user to drive and control the chemical injection system 1.
사용자 단말(20)은 컨트롤러(30)를 구동시키는 신호를 생성하여, 컨트롤러(30)를 제어하여 약액 주입 장치(10)을 구동시킬 수 있다. The user terminal 20 may generate a signal that drives the controller 30 and control the controller 30 to drive the chemical injection device 10.
또한, 사용자 단말(20)은 생체 정보 센서(40)로부터 측정된 생체 정보를 표시할 수 있으며, 약액 주입 장치(10)의 상태 정보를 표시할 수 있다. Additionally, the user terminal 20 can display biometric information measured from the biometric information sensor 40 and status information of the chemical injection device 10 .
사용자 단말(20)은 유무선 통신 환경에서 이용할 수 있는 통신 단말을 의미한다. 예를 들어, 사용자 단말(20)은 스마트폰, 태블릿 PC, PC, 스마트 TV, 휴대폰, PDA(personal digital assistant), 랩톱, 미디어 플레이어, 마이크로 서버, GPS(global positioning system) 장치, 전자책 단말기, 디지털방송용 단말기, 네비게이션, 키오스크, MP3 플레이어, 디지털 카메라, 가전기기, 카메라가 탑재된 디바이스 및 기타 모바일 또는 비모바일 컴퓨팅 장치일 수 있다. The user terminal 20 refers to a communication terminal that can be used in a wired or wireless communication environment. For example, the user terminal 20 includes a smartphone, a tablet PC, a PC, a smart TV, a mobile phone, a personal digital assistant (PDA), a laptop, a media player, a micro server, a global positioning system (GPS) device, an e-book terminal, It may be a digital broadcasting terminal, navigation, kiosk, MP3 player, digital camera, home appliance, camera-equipped device, and other mobile or non-mobile computing devices.
또한, 사용자 단말(20)은 통신 기능 및 데이터 프로세싱 기능을 구비한 시계, 안경, 헤어 밴드 및 반지 등의 웨어러블 디바이스일 수 있다. 그러나, 상술한 바와 같이 인터넷 통신이 가능한 애플리케이션을 탑재한 단말은 제한 없이 차용될 수 있다. Additionally, the user terminal 20 may be a wearable device such as a watch, glasses, hair band, or ring equipped with a communication function and data processing function. However, as described above, terminals equipped with applications capable of Internet communication can be borrowed without limitation.
사용자 단말(20)은 미리 등록된 컨트롤러(30)와 1대1로 연결될 수 있다. 사용자 단말(20)은 외부의 장치로부터의 컨트롤러(30)가 구동 및 제어되는 것을 막기 위해서, 컨트롤러(30)와 암호화되어 연결될 수 있다. The user terminal 20 can be connected one-to-one with the pre-registered controller 30. The user terminal 20 may be encrypted and connected to the controller 30 in order to prevent the controller 30 from being driven and controlled by an external device.
일 실시예로, 사용자 단말(20)과 컨트롤러(30)는 각각 분리되어 별도의 장치로 구비될 수 있다. 예컨대, 컨트롤러(30)는 약액 주입 장치(10)가 장착된 대상자에게 구비되고, 사용자 단말(20)은 대상자 또는 제3 자에게 구비될 수 있다. 보호자에 의해서 사용자 단말(20)이 구동되어, 약액 주입 시스템(1)의 안전성을 높일 수 있다. In one embodiment, the user terminal 20 and the controller 30 may be separated and provided as separate devices. For example, the controller 30 may be provided to a subject equipped with the chemical injection device 10, and the user terminal 20 may be provided to the subject or a third party. The user terminal 20 is driven by the guardian, thereby improving the safety of the chemical injection system 1.
다른 실시예로, 사용자 단말(20)과 컨트롤러(30)는 하나의 디바이스로 구비될 수 있다. 사용자 단말(20)과 하나로 구비된 컨트롤러(30)가 약액 주입 장치(10)와 통신하여, 약물의 주입을 제어할 수 있다. In another embodiment, the user terminal 20 and the controller 30 may be provided as one device. The controller 30, which is provided as one with the user terminal 20, can communicate with the drug injection device 10 to control the injection of the drug.
컨트롤러(30)는 약액 주입 장치(10)와 데이터를 송수신하는 기능을 수행하며, 약액 주입 장치(10)로 인슐린 등의 약물의 주입과 관련된 제어 신호를 전송하고, 생체 정보 센서(40)로부터 혈당 등의 생체값의 측정과 관련된 제어 신호를 수신 받을 수 있다. The controller 30 performs a function of transmitting and receiving data with the drug injection device 10, transmits a control signal related to the injection of drugs such as insulin to the drug injection device 10, and detects blood sugar levels from the biometric information sensor 40. Control signals related to measurement of biometric values, such as the like, can be received.
컨트롤러(30)는 일 예로 약액 주입 장치(10)로 사용자의 현 상태를 측정하라는 지시 요청을 전송하고, 지시 요청의 응답으로 약액 주입 장치(10)로부터 측정 데이터를 수신 받을 수 있다. For example, the controller 30 may transmit an instruction request to measure the user's current state to the chemical injection device 10 and receive measurement data from the chemical injection device 10 in response to the instruction request.
생체 정보 센서(40)는 목적에 따라 사용자의 혈당값, 혈압, 심박수 등의 생체값을 측정하는 기능을 수행할 수 있다. 생체 정보 센서(40)에서 측정된 데이터는 컨트롤러(30)에 전달될 수 있으며, 측정된 데이터를 기초로 약물의 주입 주기 또는 주입량이 설정될 수 있다. 생체 정보 센서(40)에서 측정된 데이터는 사용자 단말(20)로 전달되어 표시될 수 있다.The biometric information sensor 40 may perform a function of measuring the user's biometric values such as blood sugar level, blood pressure, and heart rate depending on the purpose. Data measured by the biometric sensor 40 may be transmitted to the controller 30, and the injection cycle or injection amount of the drug may be set based on the measured data. Data measured by the biometric information sensor 40 may be transmitted to the user terminal 20 and displayed.
선택적 실시예로서, 생체 정보 센서(40)는 대상체의 혈당량을 측정하는 센서일 수 있다. 연속 혈당 측정(CGM: Continuous Glucose Monitoring) 센서일 수 있다. 연속 혈당 측정 센서는 대상체에 부착되어 연속적으로 혈당량을 모니터링 할 수 있다.As an optional embodiment, the biometric information sensor 40 may be a sensor that measures the blood sugar level of the subject. It may be a continuous glucose monitoring (CGM) sensor. A continuous blood sugar measurement sensor can be attached to an object and continuously monitor blood sugar level.
사용자 단말(20), 컨트롤러(30) 및 약액 주입 장치(10)는 네트워크를 이용하여 통신을 수행할 수 있다. The user terminal 20, the controller 30, and the chemical injection device 10 may communicate using a network.
예를 들어, 네트워크는 근거리 통신망(Local Area Network; LAN), 광역 통신망(Wide Area Network; WAN), 부가가치 통신망(Value Added Network; VAN), 이동 통신망(mobile radio communication network), 위성 통신망 및 이들의 상호 조합을 포함하며, 각 네트워크 구성 주체가 서로 원활하게 통신을 할 수 있도록 하는 포괄적인 의미의 데이터 통신망이며, 유선 인터넷, 무선 인터넷 및 모바일 무선 통신망을 포함할 수 있다. For example, networks include Local Area Network (LAN), Wide Area Network (WAN), Value Added Network (VAN), mobile radio communication network, satellite communication network, and their It is a comprehensive data communication network that includes mutual combinations and allows each network member to communicate smoothly with each other, and may include wired Internet, wireless Internet, and mobile wireless communication networks.
또한, 무선 통신은 예를 들어, 무선 랜(Wi-Fi), 블루투스, 블루투스 저 에너지(Bluetooth low energy), 지그비, WFD(Wi-Fi Direct), UWB(ultra wideband), 적외선 통신(IrDA, infrared Data Association), NFC(Near Field Communication), 5G 등이 있을 수 있으나, 이에 한정되는 것은 아니다.In addition, wireless communications include, for example, wireless LAN (Wi-Fi), Bluetooth, Bluetooth low energy, ZigBee, WFD (Wi-Fi Direct), UWB (ultra wideband), and infrared communications (IrDA). Data Association), NFC (Near Field Communication), 5G, etc., but are not limited to these.
도 2는 본 발명의 일 실시예에 따른 약액 주입 장치를 도시하는 블록도이다. 도 3은 본 발명의 일 실시예에 따른 약액 주입 장치를 부분적으로 도시한 사시도이다. 도 4는 도 3의 A부분을 도시한 측단면도이다. 도 5는 본 발명의 일 실시예에 따른 압력생성부를 도시한 평면도이다. 도 6은 도 5의 B부분을 도시한 확대도이다. 도 8은 본 발명의 일 실시예에 따른 밸브부를 개략적으로 도시한 도면이다. 도 9는 본 발명의 일 실시예에 따른 센서부, 제어부 등을 도시한 블록도이다. 도 10은 도 8에서 약액이 유동하는 상태를 도시한 도면이다.Figure 2 is a block diagram showing a chemical injection device according to an embodiment of the present invention. Figure 3 is a perspective view partially showing a chemical injection device according to an embodiment of the present invention. Figure 4 is a side cross-sectional view showing part A of Figure 3. Figure 5 is a plan view showing a pressure generator according to an embodiment of the present invention. Figure 6 is an enlarged view showing part B of Figure 5. Figure 8 is a diagram schematically showing a valve unit according to an embodiment of the present invention. Figure 9 is a block diagram showing a sensor unit, a control unit, etc. according to an embodiment of the present invention. FIG. 10 is a diagram showing the state in which the chemical solution flows in FIG. 8.
도 2, 도 3, 도 9를 참조하면, 본 발명의 일 실시예에 따른 약액 주입 장치(10)는 약액(D)을 주입할 사용자의 신체(HB)에 부착되는 것으로, 내부에 저장된 약액(D)을 사용자에게 미리 설정된 주기 또는 미리 설정된 양으로 주입할 수 있다.Referring to FIGS. 2, 3, and 9, the chemical injection device 10 according to an embodiment of the present invention is attached to the body (HB) of the user to inject the chemical liquid (D), and contains the chemical liquid (D) stored therein. D) can be injected to the user at a preset cycle or in a preset amount.
약액 주입 장치(10)는 주입되는 약액(D)의 종류에 따라 다양한 용도로 사용될 수 있다. 예컨대, 약액(D)은 당뇨병 환자를 위한 인슐린 계열 약액을 포함할 수 있고, 기타 췌장을 위한 약액, 심장용 약액 기타 다양한 종류의 약액을 포함할 수 있다.The chemical injection device 10 can be used for various purposes depending on the type of chemical solution D to be injected. For example, the drug solution D may include an insulin-based drug solution for diabetic patients, a drug solution for the pancreas, a drug solution for the heart, and other various types of drug solutions.
도 2, 도 3, 도 9를 참조하면, 본 발명의 일 실시예에 따른 약액 주입 장치(10)는, 베이스부(100), 레저버 유닛(200), 기판부(300), 압력생성부(400), 밸브부(500), 니들 어셈블리(600), 전원부(700), 센서부(810), 제어부(850)를 포함할 수 있다. Referring to FIGS. 2, 3, and 9, the chemical injection device 10 according to an embodiment of the present invention includes a base portion 100, a reservoir unit 200, a substrate portion 300, and a pressure generator. It may include (400), a valve unit (500), a needle assembly (600), a power unit (700), a sensor unit (810), and a control unit (850).
도 3을 참조하면, 본 발명의 일 실시예에 따른 베이스부(100)는 베이스본체(110), 실링부재(130)를 포함할 수 있다.Referring to FIG. 3, the base portion 100 according to an embodiment of the present invention may include a base body 110 and a sealing member 130.
본 발명의 일 실시예에 따른 베이스본체(110)는 약액 주입 장치(10)의 외관을 형성하는 것으로, 뒤에 설명할 레저버 유닛(200), 기판부(300), 압력생성부(400), 밸브부(500), 니들 어셈블리(600), 전원부(700), 센서부(810), 제어부(850)가 설치될 수 있고, 내부가 중공으로 형성될 수 있다.The base body 110 according to an embodiment of the present invention forms the exterior of the chemical injection device 10 and includes a reservoir unit 200, a substrate portion 300, a pressure generator 400, which will be described later, The valve unit 500, needle assembly 600, power unit 700, sensor unit 810, and control unit 850 may be installed, and the interior may be hollow.
베이스본체(110)의 일면(도 3 기준 하면)은 약액 주입 장치(10)를 통해 약액(D)을 주입할 대상체인 환자 등 사용자의 신체(HB)에 부착가능한 것으로, 접착부재(도면 미도시)가 도포될 수 있다.One side of the base body 110 (lower surface in FIG. 3) is attachable to the body (HB) of a user such as a patient who is to be injected with the drug solution (D) through the drug injection device 10, and has an adhesive member (not shown). ) can be applied.
선택적 실시예로서, 접착부재는 별도의 커버(도면 미도시)에 의해 커버될 수 있고, 사용자의 신체(HB)에 약액 주입 장치(10), 구체적으로 베이스본체(110)를 부착하고자 하는 경우에 접착부재를 덮고 있는 커버를 제거할 수 있다.As an optional embodiment, the adhesive member may be covered by a separate cover (not shown), in the case where it is desired to attach the chemical injection device 10, specifically the base body 110, to the user's body (HB). The cover covering the adhesive member can be removed.
이로 인하여 접착부재가 접착력을 발휘하며, 약액 주입 장치(10), 구체적으로 베이스본체(110)가 사용자의 신체에 부착된 상태를 유지할 수 있도록 하는 효과가 있다.As a result, the adhesive member exerts adhesive force and has the effect of maintaining the chemical injection device 10, specifically the base body 110, attached to the user's body.
도 3을 참조하면, 베이스본체(110)는 원판 형상으로 형성되나 이에 한정하는 것은 아니고, 베이스본체(110)의 중심을 기준으로 둘레 방향을 따라 측벽이 연장 형성되고, 측벽으로 인해 형성되는 내측 공간에 레저버 유닛(200), 기판부(300), 압력생성부(400), 밸브부(500), 니들 어셈블리(600), 전원부(700), 센서부(810), 제어부(850)가 배치될 수 있는 등 다양한 변형 실시가 가능하다.Referring to FIG. 3, the base body 110 is formed in a disk shape, but is not limited to this, and the side wall extends along the circumferential direction based on the center of the base body 110, and the inner space formed by the side wall is formed. A reservoir unit 200, a substrate unit 300, a pressure generator 400, a valve unit 500, a needle assembly 600, a power unit 700, a sensor unit 810, and a control unit 850 are disposed. Various modifications are possible, such as:
선택적 실시예로서, 베이스본체(110)는 사각판 형상 등 다각형 형상으로 형성될 수 있다.As an optional embodiment, the base body 110 may be formed in a polygonal shape, such as a square plate shape.
도면에 도시하지는 않았지만, 약액 주입 장치(10), 구체적으로 베이스부(100)는, 베이스본체(110) 및 베이스본체(110) 상에 배치되는 레저버 유닛(200), 기판부(300), 압력생성부(400), 밸브부(500), 니들 어셈블리(600), 전원부(700), 센서부(810), 제어부(850)를 커버하는 커버부(도면 미도시)를 포함할 수 있음은 물론이다.Although not shown in the drawing, the chemical injection device 10, specifically the base portion 100, includes a base body 110, a reservoir unit 200 disposed on the base body 110, a substrate portion 300, It may include a cover part (not shown) covering the pressure generating unit 400, valve unit 500, needle assembly 600, power unit 700, sensor unit 810, and control unit 850. Of course.
커버부가 베이스본체(110)를 커버하며, 베이스본체(110)에 연결됨으로 인하여 외부로부터 이물질이 약액 주입 장치(10)의 내부로 유입되는 것을 차단할 수 있다.The cover portion covers the base body 110 and is connected to the base body 110, thereby preventing foreign substances from entering the chemical injection device 10 from the outside.
도 3, 도 4를 참조하면, 본 발명의 일 실시예에 따른 베이스본체(110)에는 뒤에 설명할 니들 어셈블리(600)가 관통가능하게 연결될 수 있다.Referring to FIGS. 3 and 4, a needle assembly 600, which will be described later, may be connected to the base body 110 according to an embodiment of the present invention.
도 4를 참조하면, 니들 어셈블리(600)는 캐뉼라(CN), 니들부(ND)를 포함할 수 있고, 캐뉼라(CN)의 내부에서 니들부(ND)가 미리 설정된 방향을 따라 이동할 수 있다. Referring to FIG. 4 , the needle assembly 600 may include a cannula (CN) and a needle portion (ND), and the needle portion (ND) may move within the cannula (CN) along a preset direction.
즉, 베이스본체(110)를 통과하여 외부를 향해 니들부(ND)가 이동하는 경우에는 사용자의 신체에 접촉, 침투하여 약액(D)을 사용자에게 주입할 수 있고, 사용이 완료된 경우에는 반대 방향으로 니들부(ND)가 이동하여, 사용자의 신체에서 이탈할 수 있다.That is, when the needle part (ND) passes through the base body 110 and moves outward, it can contact and penetrate the user's body and inject the chemical solution (D) into the user, and when use is completed, in the opposite direction. The needle part ND may move and leave the user's body.
본 발명의 일 실시예에 따른 니들부(ND)의 외측 단부에는 개구부가 형성될 수 있고, 상기 개구부를 통해서 약액(D)이 사용자의 체내(HB)에 주입될 수 있다.An opening may be formed at the outer end of the needle portion (ND) according to an embodiment of the present invention, and the medical solution (D) may be injected into the user's body (HB) through the opening.
선택적 실시예로서, 캐뉼라(CN)와 니들부(ND)는 연결되며 일체로 형성될 수 있다. 이 경우 캐뉼라(CN)의 재질과 니들부(ND)의 재질은 다르게 형성될 수 있다.As an optional embodiment, the cannula (CN) and the needle portion (ND) may be connected and formed as one piece. In this case, the material of the cannula (CN) and the material of the needle portion (ND) may be formed differently.
도 4를 참조하면, 베이스본체(110)에는 니들 어셈블리(600), 구체적으로 내측에서 니들부(ND)의 이동이 가능한 캐뉼라(CN)가 통과가능하게 삽입홀부(110h)가 형성될 수 있고, 삽입홀부(110h)에는 실링부재(130)가 배치될 수 있다.Referring to FIG. 4, the base body 110 may be formed with an insertion hole 110h through which the needle assembly 600, specifically the cannula CN through which the needle portion ND can move on the inside, can pass, A sealing member 130 may be disposed in the insertion hole portion 110h.
도 4를 참조하면, 실링부재(130)는 탄성 변형이 가능한 재질로 형성될 수 있고, 니들 어셈블리(600), 구체적으로 캐뉼라(CN)가 관통하며 접촉할 수 있도록 홀부(도면부호 미설정)가 형성될 수 있다.Referring to FIG. 4, the sealing member 130 may be formed of a material capable of elastic deformation, and may have a hole (reference numeral not set) through which the needle assembly 600, specifically the cannula CN, can penetrate and contact the sealing member 130. can be formed.
실링부재(130)가 베이스본체(110)와 캐뉼라(CN) 사이에 배치되고, 탄성 변형이 가능한 재질로 형성됨으로 인하여, 베이스본체(110)에 형성되는 삽입홀부(110h)의 내주면과 캐뉼라(CN) 사이에 형성되는 틈을 밀폐시킬 수 있고, 사용자의 신체(HB)로 주입되는 약액(D)이 다시 약액 주입 장치(10), 베이스본체(110)를 통과하여 내부 공간으로 유입되는 것을 방지할 수 있는 효과가 있다.Since the sealing member 130 is disposed between the base body 110 and the cannula (CN) and is made of an elastically deformable material, the inner peripheral surface of the insertion hole portion 110h formed in the base body 110 and the cannula (CN) ) can seal the gap formed between them, and prevent the chemical solution (D) injected into the user's body (HB) from passing through the chemical injection device 10 and the base body 110 and flowing into the internal space. There is a possible effect.
도 2, 도 3, 도 9를 참조하면, 본 발명의 일 실시예에 따른 레저버 유닛(200)은 약액(D)이 수용되는 것으로, 베이스부(100), 구체적으로 베이스본체(110)에 배치되며, 니들 어셈블리(600)와 연결될 수 있다.Referring to FIGS. 2, 3, and 9, the reservoir unit 200 according to an embodiment of the present invention accommodates the chemical solution (D), and is installed in the base portion 100, specifically the base body 110. It is placed and may be connected to the needle assembly 600.
레저버 유닛(200)의 내부 공간에는 약액(D)이 저장될 수 있고, 내부가 중공이며, 튜브 형상으로 형성되는 공급관(201)을 통해 압력생성부(400)에 약액(D)을 공급할 수 있다.The chemical liquid (D) can be stored in the internal space of the reservoir unit 200, and the interior is hollow, and the chemical liquid (D) can be supplied to the pressure generator 400 through the supply pipe 201 formed in a tube shape. there is.
선택적 실시예로서, 별도의 외부 장치(도면 미도시)를 통해 레저버 유닛(200)에 약액(D)을 주입할 수 있다.As an optional embodiment, the chemical solution (D) may be injected into the reservoir unit 200 through a separate external device (not shown).
레저버 유닛(200)의 일측에는 내부가 중공인 공급관(201)이 연장 형성될 수 있고, 레저버 유닛(200)의 내부 공간과 외부 공간을 연통시킬 수 있다. A supply pipe 201 having a hollow interior may be extended on one side of the reservoir unit 200, and the internal space of the reservoir unit 200 may be communicated with the external space.
본 발명의 일 실시예에 따른 레저버 유닛(200)에 형성되는 공급관(201)은 뒤에 설명할 압력생성부(400)와 연결되는 것으로, 압력생성부(400)에서 압력이 생성됨에 따라 약액(D)이 미리 설정되는 방향, 즉, 레저버 유닛(200)에서 니들 어셈블리(600)를 거쳐 사용자의 체내(HB)에 주입되는 방향으로 유동될 수 있다.The supply pipe 201 formed in the reservoir unit 200 according to an embodiment of the present invention is connected to the pressure generator 400, which will be described later, and as pressure is generated in the pressure generator 400, the chemical liquid ( D) may flow in a preset direction, that is, in the direction of injection from the reservoir unit 200 through the needle assembly 600 into the user's body (HB).
이에 따라 레저버 유닛(200)에서 약액(D)이 공급관(201)을 통해 압력생성부(400)로 추가적으로 유입될 수 있고, 압력생성부(400)에서 유동하는 약액(D)의 압력을 증가시켜 뒤에 설명할 밸브부(500), 니들 어셈블리(600)로 약액(D)을 공급할 수 있는 효과가 있다.Accordingly, the chemical liquid (D) from the reservoir unit 200 can additionally flow into the pressure generator 400 through the supply pipe 201, and the pressure of the chemical liquid (D) flowing in the pressure generator 400 is increased. This has the effect of supplying the chemical solution (D) to the valve unit 500 and needle assembly 600, which will be explained later.
도 3을 참조하면, 본 발명의 일 실시예에 따른 기판부(300)는 베이스부(100), 구체적으로 베이스본체(110) 상에 설치되는 것으로, 압력생성부(400), 니들 어셈블리(600)와 전원부(700)가 전기적으로 연결될 때, 전기적 경로를 제공할 수 있다.Referring to FIG. 3, the substrate portion 300 according to an embodiment of the present invention is installed on the base portion 100, specifically the base body 110, and includes a pressure generating portion 400 and a needle assembly 600. ) and the power supply unit 700 are electrically connected, an electrical path can be provided.
선택적 실시예로서, 기판부(300)는 인쇄 회로 기판(printed circuit board, PCB)일 수 있다.As an optional embodiment, the substrate 300 may be a printed circuit board (PCB).
도면에 도시하지 않았지만, 전원부(700)는 기판부(300)와 베이스본체(110)의 일면(도 3 기준 저면) 사이에 배치되며, 압력생성부(400), 니들 어셈블리(600)와 전기적으로 연결될 수 있고, 압력생성부(400), 니들 어셈블리(600)로 전압을 인가할 수 있다.Although not shown in the drawing, the power supply unit 700 is disposed between the substrate unit 300 and one surface of the base body 110 (bottom surface based on FIG. 3), and is electrically connected to the pressure generating unit 400 and the needle assembly 600. It can be connected, and voltage can be applied to the pressure generator 400 and the needle assembly 600.
도 4를 참조하면, 본 발명의 일 실시예에 따른 기판부(300)에는 니들 어셈블리(600), 구체적으로 내부에서 니들부(ND)가 이동이 가능한 캐뉼라(CN)가 통과가능하도록 홀부(도면부호 미설정)가 형성될 수 있다.Referring to FIG. 4, the substrate portion 300 according to an embodiment of the present invention has a needle assembly 600, specifically a hole portion (drawing) so that a cannula (CN) within which the needle portion (ND) can move can pass. (sign not set) may be formed.
그러나 이에 한정하는 것은 아니고 니들 어셈블리(600), 구체적으로 캐뉼라(CN)가 베이스본체(110)의 내측 공간에서 기판부(300)가 배치되지 않은 영역을 지나 베이스본체(110)에 형성되는 삽입홀부(110h)를 통과하는 등 다양한 변형 실시가 가능하다.However, it is not limited to this, and the needle assembly 600, specifically the cannula CN, passes through the area where the substrate 300 is not disposed in the inner space of the base body 110, and then passes through the insertion hole formed in the base body 110. Various modifications are possible, such as passing (110h).
선택적 실시예로서, 니들부(ND)는 캐뉼라(CN)의 내부에서 미리 설정되는 방향을 따라 이동하는 방식이 아니라, 니들부(ND)와 캐뉼라(CN)이 연결되며 일체로 형성될 수 있다.As an optional embodiment, the needle portion (ND) may not move along a preset direction inside the cannula (CN), but the needle portion (ND) and the cannula (CN) may be connected and formed as one body.
이 경우에 캐뉼라(CN)와 니들부(ND)는 서로 다른 재질로 형성될 수 있고, 니들부(ND)의 강성이 캐뉼라(CN)의 강성보다 상대적으로 크게 형성될 수 있다.In this case, the cannula (CN) and the needle portion (ND) may be formed of different materials, and the stiffness of the needle portion (ND) may be relatively greater than that of the cannula (CN).
기판부(300)에는 제어부(850)가 배치될 수 있고, 제어부(850)는 압력생성부(400)와 전기적으로 연결되며, 뒤에 설명할 센서부(810)로부터 약액(D)의 유량에 관한 정보를 전달받아 압력생성부(400)로 전기적 신호를 전달하여 압력생성부(400)의 구동을 제어할 수 있다.A control unit 850 may be disposed on the substrate unit 300, and the control unit 850 is electrically connected to the pressure generator 400, and provides information on the flow rate of the chemical solution (D) from the sensor unit 810, which will be described later. By receiving information and transmitting an electrical signal to the pressure generator 400, the operation of the pressure generator 400 can be controlled.
이에 더하여 제어부(850)는 뒤에 설명할 센서부(810)와 전기적으로 연결될 수 있고, 센서부(810)로부터 약액(D)의 유량에 관한 정보를 전달받아 뒤에 설명할 압력생성부(400)로 전기적 신호를 전달하여 압력생성부(400)의 구동을 제어할 수 있다.In addition, the control unit 850 may be electrically connected to the sensor unit 810, which will be explained later, and receives information about the flow rate of the chemical solution (D) from the sensor unit 810 to the pressure generator 400, which will be explained later. The operation of the pressure generator 400 can be controlled by transmitting an electrical signal.
도 2, 도 3, 도 5 및 도 6을 참조하면, 본 발명의 일 실시예에 따른 압력생성부(400)는 레저버 유닛(200)과 연결되는 것으로, 레저버 유닛(200)과 밸브부(500) 사이에 배치될 수 있다. Referring to FIGS. 2, 3, 5, and 6, the pressure generating unit 400 according to an embodiment of the present invention is connected to the reservoir unit 200, and the reservoir unit 200 and the valve unit It can be placed between (500).
본 발명의 일 실시예에 따른 압력생성부(400)는 레저버 유닛(200)으로부터 공급되는 약액(D)의 유동 경로를 제공할 수 있고, 미리 설정되는 방향을 따라 약액(D)이 유동하는 동안 약액(D)의 압력을 증가시킬 수 있는 효과가 있다.The pressure generator 400 according to an embodiment of the present invention can provide a flow path for the chemical liquid (D) supplied from the reservoir unit 200, and the chemical liquid (D) flows along a preset direction. It has the effect of increasing the pressure of the chemical solution (D).
본 발명의 일 실시예에 따른 압력생성부(400)에 의해 증가하는 약액(D)의 압력은 뒤에 설명할 밸브부(500)로 전달될 수 있고, 상기 압력을 가지는 약액(D)이 밸브부(500)로 전달되며, 미리 설정되는 유량만큼 밸브부(500)로 유입되면 밸브부(500)에서 니들 어셈블리(600)를 통해 사용자의 체내(HB)에 주입될 수 있다.The pressure of the chemical liquid (D) increased by the pressure generator 400 according to an embodiment of the present invention may be transmitted to the valve unit 500, which will be described later, and the chemical liquid (D) having the pressure may be transmitted to the valve unit. It is delivered to 500, and when a preset flow rate flows into the valve unit 500, it can be injected from the valve unit 500 into the user's body (HB) through the needle assembly 600.
도 5, 도 6을 참조하면, 본 발명의 일 실시예에 따른 압력생성부(400)는 압력생성본체(410), 전극부(430)를 포함할 수 있다. 압력생성본체(410)는 베이스본체(110)의 내측에 배치되는 것으로, 기판부(300)에 결합될 수 있다.Referring to FIGS. 5 and 6 , the pressure generator 400 according to an embodiment of the present invention may include a pressure generator body 410 and an electrode portion 430. The pressure generating body 410 is disposed inside the base body 110 and may be coupled to the substrate portion 300.
도 3, 도 5를 참조하면, 압력생성본체(410)에는 체결홀부(411)가 홀부의 형상으로 형성될 수 있고, 기판부(300)에 형성되는 돌출부(301)가 체결홀부(411)를 통과할 수 있다. 이로 인하여 기판부(300) 상에서 압력생성본체(410)의 위치를 안정적으로 고정시킬 수 있는 효과가 있다.Referring to FIGS. 3 and 5, the pressure generating body 410 may have a fastening hole 411 formed in the shape of a hole, and a protrusion 301 formed on the substrate 300 may have a fastening hole 411. You can pass. This has the effect of stably fixing the position of the pressure generating body 410 on the substrate 300.
압력생성본체(410)에 형성되는 체결홀부(411)는 복수 개가 구비될 수 있고, 압력생성본체(410)의 중심을 기준으로 원점 대칭을 이루며 배치될 수 있다. A plurality of fastening hole portions 411 formed in the pressure generating body 410 may be provided, and may be arranged symmetrically with respect to the origin with respect to the center of the pressure generating body 410.
압력생성본체(410)의 중심을 기준으로 복수의 지점에서 기판부(300)와 연결됨으로 인하여, 압력생성본체(410)가 기판부(300) 상에서 흔들리는 것을 방지할 수 있고, 안정적으로 위치 고정될 수 있다. By being connected to the substrate portion 300 at a plurality of points based on the center of the pressure generating body 410, the pressure generating body 410 can be prevented from shaking on the substrate portion 300 and can be stably fixed in position. You can.
도 5를 참조하면, 본 발명의 일 실시예에 따른 압력생성본체(410)에는 유입홀부(412), 배출홀부(413)가 각각 형성될 수 있다. 유입홀부(412)는 레저버 유닛(200)에 형성되는 공급관(201)과 연통되는 것으로, 유입홀부(412)를 통해 압력생성본체(410)에 약액(D)이 유입될 수 있다.Referring to FIG. 5, an inlet hole portion 412 and an discharge hole portion 413 may be formed in the pressure generating body 410 according to an embodiment of the present invention, respectively. The inlet hole portion 412 is in communication with the supply pipe 201 formed in the reservoir unit 200, and the chemical solution (D) can flow into the pressure generating body 410 through the inlet hole portion 412.
도 3, 도 5를 참조하면, 압력생성본체(410)에 형성되는 배출홀부(413)는 뒤에 설명할 밸브부(500)와 연통되는 것으로, 압력생성본체(410)에 형성되는 유동 경로를 거친 약액(D)이 배출되며 밸브부(500)로 유동될 수 있다.Referring to FIGS. 3 and 5, the discharge hole portion 413 formed in the pressure generating body 410 is in communication with the valve portion 500, which will be described later, and passes through the flow path formed in the pressure generating main body 410. The chemical solution (D) is discharged and may flow into the valve unit 500.
도 5, 도 6을 참조하면, 본 발명의 일 실시예에 따른 압력생성본체(410)에는 제1유로부(414), 제2유로부(415)가 형성될 수 있다. 제1유로부(414), 제2유로부(415)는 압력생성본체(410)에 형성되는 유입홀부(412)와 배출홀부(413)와 연통되며, 유입홀부(412)와 배출홀부(413) 사이에 형성될 수 있다.Referring to FIGS. 5 and 6, a first flow path portion 414 and a second flow path portion 415 may be formed in the pressure generating body 410 according to an embodiment of the present invention. The first passage portion 414 and the second passage portion 415 communicate with the inlet hole portion 412 and the discharge hole portion 413 formed in the pressure generating body 410, and the inlet hole portion 412 and the discharge hole portion 413 ) can be formed between.
본 발명의 일 실시예에 따른 제1유로부(414), 제2유로부(415)는 연통될 수 있고, 각각 복수 개가 구비될 수 있다. 제1유로부(414), 제2유로부(415)는 서로 순차적으로 연통되며 배치될 수 있다.The first flow path portion 414 and the second flow path portion 415 according to an embodiment of the present invention may be in communication, and may each be provided in plural numbers. The first flow path portion 414 and the second flow path portion 415 may be arranged to sequentially communicate with each other.
도 5, 도 6을 참조하면, 제1유로부(414)는 유입홀부(412)를 통해 압력생성본체(410)로 유입되는 약액(D)의 유동 경로를 형성하는 것으로, 복수 개가 구비될 수 있다. 제1유로부(414)는 미리 설정되는 방향(도 6 기준 상하 방향)을 따라 연장 형성되며, 복수 개의 제1유로부(414)는 나란하게 배치될 수 있다. 복수 개의 제1유로부(414) 사이에는 격벽부(416)가 배치될 수 있다. Referring to Figures 5 and 6, the first flow path portion 414 forms a flow path for the chemical solution (D) flowing into the pressure generating body 410 through the inlet hole portion 412, and may be provided in plural pieces. there is. The first passage portion 414 extends along a preset direction (up and down direction based on FIG. 6), and a plurality of first passage portions 414 may be arranged side by side. A partition wall 416 may be disposed between the plurality of first flow passage parts 414.
본 발명의 일 실시예에 따른 압력생성본체(410)에 형성되는 제1유로부(414)의 단면적은 제1유로부(414)와 연통되는 제2유로부(415)의 단면적보다 상대적으로 작게 형성될 수 있다.The cross-sectional area of the first passage portion 414 formed in the pressure generating body 410 according to an embodiment of the present invention is relatively smaller than the cross-sectional area of the second passage portion 415 communicating with the first passage portion 414. can be formed.
도 5, 도 6을 참조하면, 본 발명의 일 실시예에 따른 제1유로부(414)는 복수 개가 구비될 수 잇고, 복수 개의 제1유로부(414)의 단면적의 합은 단일로 형성되는 제2유로부(415)의 단면적보다 크게 형성될 수 있다.Referring to FIGS. 5 and 6, a plurality of first passage portions 414 according to an embodiment of the present invention may be provided, and the sum of the cross-sectional areas of the plurality of first passage portions 414 may be formed as a single It may be formed to be larger than the cross-sectional area of the second flow path portion 415.
도 6을 참조하면, 본 발명의 일 실시예에 따른 제1유로부(414)의 양측에는 서로 다른 극성을 가지는 전극부(430), 구체적으로 제1전극(430a), 제2전극(430b)이 각각 배치될 수 있다.Referring to Figure 6, on both sides of the first flow path portion 414 according to an embodiment of the present invention, electrode portions 430 having different polarities, specifically a first electrode 430a and a second electrode 430b. Each of these can be arranged.
도 6을 참조하면, 전극부(430)가 전원부(700)로부터 전압을 인가받으면, 제1유로부(414) 상에 전기장(EF)이 형성될 수 있고, 제1유로부(414)에 수용되는 약액(D)이 전기장(EF)의 방향, 즉, 제1전극(430a)에서 제2전극(430b) 방향으로 유동될 수 있다.Referring to FIG. 6, when the electrode unit 430 receives a voltage from the power supply unit 700, an electric field EF may be formed on the first passage unit 414 and is accommodated in the first passage unit 414. The chemical solution D may flow in the direction of the electric field EF, that is, from the first electrode 430a to the second electrode 430b.
즉, 제1전극(430a), 제2전극(430b)은 서로 다른 극성을 가질 수 있다. 본 명세서에서 제1전극(430a)은 양극(positive electrode), 제2전극(430b)은 음극(negative electrode)으로 형성될 수 있다.That is, the first electrode 430a and the second electrode 430b may have different polarities. In this specification, the first electrode 430a may be formed as a positive electrode, and the second electrode 430b may be formed as a negative electrode.
본 발명의 일 실시예에 따른 전극부(430)가 전원부(700)로부터 전압을 인가받기 전에는 압력생성부(400)에 수용되는 약액(D)이 이동하지 않고, 전극부(430)가 전압을 인가받아 전기장(EF)이 형성되면서 제1유로부(414) 상에 수용되는 약액(D)이 미리 설정되는 속도를 가지게 되고, 그에 따라 압력이 생성될 수 있다. Before the electrode unit 430 according to an embodiment of the present invention receives voltage from the power supply unit 700, the chemical solution (D) contained in the pressure generator 400 does not move, and the electrode unit 430 applies the voltage. As the applied electric field (EF) is formed, the chemical solution (D) accommodated in the first flow path portion 414 has a preset speed, and pressure can be generated accordingly.
도 6을 참조하면, 압력생성부(400)에 형성되는 제2유로부(415)는 제1유로부(414)와 연통되는 것으로, 약액(D)의 유동 경로를 제공할 수 있다. 제2유로부(415)는 복수 개가 구비될 수 있고, 복수 개의 제2유로부(415)는 제1유로부(414)의 유입단, 배출단에 각각 배치될 수 있다.Referring to FIG. 6, the second flow path portion 415 formed in the pressure generating unit 400 is in communication with the first flow path portion 414 and can provide a flow path for the chemical solution D. A plurality of second flow passage parts 415 may be provided, and a plurality of second flow passage parts 415 may be disposed at the inlet end and the discharge end of the first flow passage part 414, respectively.
도 6을 참조하면, 제2유로부(415)에 수용되는 약액(D)은 제1유로부(414)와 같이, 전원부(700)로부터 전압을 인가받은 전극부(430), 구체적으로 제1전극(430a), 제2전극(430b)에 의해 형성되는 전기장(EF)에 의해 약액(D)이 유동하는 것이 아니라, 제1유로부(414)에서 생성된 압력으로 다음 단계의 제1유로부(414)까지 약액(D)이 유동될 수 있다.Referring to FIG. 6, the chemical solution (D) contained in the second flow path portion 415 is, like the first flow path portion 414, an electrode portion 430 that receives a voltage from the power supply portion 700, specifically the first flow path portion 414. The chemical solution (D) does not flow due to the electric field (EF) formed by the electrode 430a and the second electrode 430b, but moves to the first flow path portion of the next step due to the pressure generated in the first flow path portion 414. The chemical solution (D) can flow up to (414).
다시 말하면, 본 발명의 일 실시예에 따른 제1유로부(414), 제2유로부(415)는 복수 개가 구비되며, 양측에 전극부(430)가 배치되는 제1유로부(414)를 통과한 약액(D)이 제2유로부(415)로 진입하는 과정을 '단일 단계(single step)'로 정의할 수 있다.In other words, a plurality of first passage portions 414 and second passage portions 415 according to an embodiment of the present invention are provided, and the first passage portion 414 on which electrode portions 430 are disposed on both sides The process by which the passed chemical solution (D) enters the second flow path portion 415 can be defined as a 'single step'.
복수 개의 제1유로부(414), 제2유로부(415), 전극부(430)는 서로 순차적으로 배치되며, 복수 개의 단일 단계가 연결되며, '다중 단계(multiple steps)'를 형성할 수 있다.The plurality of first passage portions 414, second passage portions 415, and electrode portions 430 are sequentially arranged, and a plurality of single steps are connected to form ‘multiple steps’. there is.
단일 단계에 형성되는 제1유로부(414)를 통과하면서, 약액(D)에 압력이 생성될 수 있고, 제2유로부(415)를 통과하여 다시 다른 단일 단계에 구비되는 제1유로부(414)를 통과하면서 압력이 증가할 수 있다.Pressure can be generated in the chemical solution (D) while passing through the first passage portion 414 formed in a single stage, and passing through the second passage portion 415 again provided in another single stage ( 414), the pressure may increase.
본 발명의 일 실시예에 따른 압력생성부(400)는 다중 단계가 몇 개의 단일 단계로 이루어지는지에 따라 압력생성부(400)에서 목표로 하는 압력을 생성할 수 있는 효과가 있다.The pressure generator 400 according to an embodiment of the present invention has the effect of generating a target pressure depending on how many single steps a multiple step consists of.
선택적 실시예로서, 복수 개의 제1유로부(414)의 각 단면적의 합은 제2유로부(415)의 단면적보다 상대적으로 크게 형성될 수 있다. As an optional embodiment, the sum of the cross-sectional areas of the plurality of first passage portions 414 may be relatively larger than the cross-sectional area of the second passage portions 415.
이 경우에 베르누이 법칙에 의해 복수 개의 제1유로부(414)를 통과하는 약액(D)의 유동 속도보다 제2유로부(415)에서의 약액(D)의 유동 속도가 증가되고, 제1유로부(414)를 통과하며 생성되는 압력으로 제2유로부(415) 상에서 약액(D)이 유동될 수 있다.In this case, according to Bernoulli's law, the flow rate of the chemical solution (D) in the second flow path portion 415 increases compared to the flow rate of the chemical solution (D) passing through the plurality of first flow path portions 414, and the first flow path portion 415 increases. The chemical solution (D) may flow on the second flow path portion 415 due to the pressure generated while passing through the portion 414.
압력생성부(400)에서 생성된 압력은 뒤에 설명할 밸브부(500)로 전달될 수 있고, 압력생성부(400)에서 배출되는 약액(D)은 밸브부(500), 니들 어셈블리(600)를 거쳐 사용자의 체내(HB)에 주입될 수 있다.The pressure generated in the pressure generator 400 can be transmitted to the valve portion 500, which will be explained later, and the chemical solution (D) discharged from the pressure generator 400 is connected to the valve portion 500 and the needle assembly 600. It can be injected into the user's body (HB).
도 5, 도 6을 참조하면, 제1유로부(414), 제2유로부(415) 내에서 약액(D)의 유동 방향은 서로 다르게 형성될 수 있다. 구체적으로 제1유로부(414), 제2유로부(415) 내에서 약액의 유동 방향은 서로 반대 방향으로 형성될 수 있다.Referring to FIGS. 5 and 6 , the flow directions of the chemical solution D within the first flow path portion 414 and the second flow path portion 415 may be formed differently. Specifically, the flow direction of the chemical liquid within the first flow path portion 414 and the second flow path portion 415 may be formed in opposite directions.
이로 인하여 복수 개의 단일 단계는 서로 나란하게 병렬 배치될 수 있고, 복수 개의 단일 단계가 직렬 배치되는 것에 비하여 베이스본체(110)의 내부에서 압력생성부(400)가 차지하는 부피를 절감시킬 수 있다.As a result, a plurality of single stages can be arranged in parallel with each other, and the volume occupied by the pressure generator 400 inside the base body 110 can be reduced compared to a case where a plurality of single stages are arranged in series.
도 6을 참조하면, 약액(D)의 유동이 발생하지 않은 상태에서, 전극부(430)가 전압을 인가받으면, 발생하는 전기장(EF)에 의해 약액(D)이 유동이 발생하며 속도가 생성된다.Referring to FIG. 6, when the electrode unit 430 receives voltage in a state in which no flow of the chemical solution (D) occurs, the chemical solution (D) flows due to the generated electric field (EF) and a speed is generated. do.
그 다음에 제2유로부(415)를 거쳐 다음 단계에 배치되는 제1유로부(414)로 진입하게 되면 상기 단계에 배치되는 전극부(430)에 의해 형성되는 전기장(EF) 방향을 따라 약액(D)이 유동하게 되며, 약액(D)의 유동 속도가 증가할 수 있고 그에 따라 압력이 증가할 수 있는 효과가 있다.Then, when entering the first flow path part 414 disposed in the next step through the second flow path portion 415, the chemical solution follows the direction of the electric field (EF) formed by the electrode portion 430 disposed in the step. (D) flows, and the flow speed of the chemical solution (D) can increase, which has the effect of increasing the pressure.
도 5를 참조하면, 복수 개의 단일 단계를 거친 약액(D)은 제1유로부(414) 또는 제2유로부(415)와 연통되는 배출홀부(413)를 통해 압력생성부(400)의 외부로 배출될 수 있다.Referring to FIG. 5, the chemical solution (D) that has gone through a plurality of single stages is discharged to the outside of the pressure generator 400 through the discharge hole portion 413 in communication with the first flow path portion 414 or the second flow path portion 415. can be discharged as
도 5, 도 6을 참조하면, 본 발명의 일 실시예에 따른 전극부(430)는 압력생성본체(410)에 배치되는 것으로, 압력생성본체(410)에 형성되는 배치홀부(도면부호 미설정)에 삽입가능하다.Referring to FIGS. 5 and 6, the electrode unit 430 according to an embodiment of the present invention is disposed in the pressure generating body 410, and the placement hole portion (reference numeral not set) is formed in the pressure generating main body 410. ) can be inserted.
도 6을 참조하면, 전극부(430)는 복수 개의 전극, 구체적으로 제1전극(430a), 제2전극(430b)을 포함하고, 제1전극(430a), 제2전극(430b)은 서로 다른 극성을 가질 수 있다. 본 명세서에서 제1전극(430a)은 양극, 제2전극(430b)은 음극으로 형성될 수 있다.Referring to FIG. 6, the electrode unit 430 includes a plurality of electrodes, specifically a first electrode 430a and a second electrode 430b, and the first electrode 430a and the second electrode 430b are connected to each other. Can have different polarities. In this specification, the first electrode 430a may be formed as an anode, and the second electrode 430b may be formed as a cathode.
도 6을 참조하면, 전극부(430), 구체적으로 제1전극(430a), 제2전극(430b)은 제1유로부(414)의 양측에 각각 배치될 수 있고, 약액(D)이 유입되는 영역 측에 제1전극(430a)이 배치될 수 있고, 약액(D)이 제1유로부(414)를 통해 배출되는 영역 측에 제2전극(430b)이 배치될 수 있다.Referring to FIG. 6, the electrode portion 430, specifically the first electrode 430a and the second electrode 430b, may be disposed on both sides of the first passage portion 414, and the chemical solution D flows therein. The first electrode 430a may be disposed on the side of the area where the chemical solution D is discharged through the first passage portion 414, and the second electrode 430b may be disposed on the side of the area where the chemical solution D is discharged through the first flow path 414.
전극부(430)는 전원부(700)와 전기적으로 연결될 수 있고, 전원부(700)로부터 전압을 인가받아 전기장(EF)을 형성할 수 있다. 구체적으로 제1전극(430a), 제2전극(430b) 사이에 전기장(EF)이 형성됨에 따라 전기장(EF)과 중첩되며 배치되는 제1유로부(414)를 따라 약액(D)이 미리 설정되는 방향 즉, 전기장(EF) 방향으로 유동될 수 있는 효과가 있다.The electrode unit 430 may be electrically connected to the power supply unit 700 and may receive voltage from the power supply unit 700 to form an electric field EF. Specifically, as the electric field (EF) is formed between the first electrode (430a) and the second electrode (430b), the chemical solution (D) is preset along the first passage portion 414 that overlaps the electric field (EF). There is an effect of being able to flow in the direction of the electric field (EF).
도 7은 본 발명의 다른 실시예에 따른 압력생성부(400`)를 도시한 사시도이다. 도 7을 참조하면, 압력생성부(400`)는 압력생성본체(410`), 전극부(430`)를 포함할 수 있다. 전극부(430`)는 제1전극(430`a), 제2전극(430`b)을 포함할 수 있고, 복수 개가 구비될 수 있다.Figure 7 is a perspective view showing the pressure generator 400' according to another embodiment of the present invention. Referring to Figure 7, the pressure generating unit 400' may include a pressure generating body 410' and an electrode unit 430'. The electrode portion 430` may include a first electrode 430`a and a second electrode 430`b, and may be provided in plural pieces.
본 발명의 다른 실시예에 따른 압력생성부(400`)는 제1유로부(414`)의 양측에 배치되는 전극부(430`), 구체적으로 제1전극(430`a), 제2전극(430`b)이 각각 단일의 전극으로 배치되는 점을 제외하고는 압력생성부(400`)를 통과하는 약액(D)이 유동됨에 따라 압력이 증가하는 구성, 작동원리 및 효과는 본 발명의 일 실시예에 따른 압력생성부(400)와 동일하므로 이와 중복되는 범위에서 자세한 설명은 생략한다.The pressure generator 400' according to another embodiment of the present invention includes electrode parts 430' disposed on both sides of the first flow path part 414', specifically the first electrode 430'a and the second electrode. Except that (430'b) is each disposed as a single electrode, the configuration, operating principle, and effect of increasing the pressure as the chemical solution (D) flowing through the pressure generator (400') flows are the same as those of the present invention. Since it is the same as the pressure generating unit 400 according to one embodiment, detailed description will be omitted to the extent of overlap.
도 2, 도 3, 도 6, 도 7을 참조하면, 본 발명의 일 실시예에 따른 밸브부(500)는, 압력생성부(400)와 니들 어셈블리(600) 사이에 배치되는 것으로, 미리 설정되는 양만큼 약액(D)을 니들 어셈블리(600)로 공급할 수 있다.Referring to FIGS. 2, 3, 6, and 7, the valve unit 500 according to an embodiment of the present invention is disposed between the pressure generating unit 400 and the needle assembly 600, and is preset. A sufficient amount of chemical solution (D) can be supplied to the needle assembly 600.
본 발명의 일 실시예에 따른 밸브부(500)는, 밸브본체(510), 변형부(530)를 포함할 수 있다. 밸브본체(510)는 압력생성부(400)로부터 유입되는 약액(D)이 유동가능하도록 유동 경로를 제공하는 것으로, 제1밸브유로(511), 제2밸브유로(513)가 형성될 수 있다.The valve unit 500 according to an embodiment of the present invention may include a valve body 510 and a deformation unit 530. The valve body 510 provides a flow path so that the chemical solution (D) flowing in from the pressure generator 400 can flow, and a first valve flow path 511 and a second valve flow path 513 can be formed. .
구체적으로 제1밸브유로(511)는 압력생성부(400)와 연결되며 약액(D)의 유입 경로를 제공하고, 제2밸브유로(513)는 니들 어셈블리(600)와 연결되며 약액(D)의 배출 경로를 제공하는 것이다. Specifically, the first valve passage 511 is connected to the pressure generator 400 and provides an inflow path for the chemical liquid (D), and the second valve passage 513 is connected to the needle assembly 600 and provides an inflow path for the chemical liquid (D). The purpose is to provide an emission route for .
제1밸브유로(511), 제2밸브유로(513)는 내부가 중공이며, 튜브 형상으로 형성될 수 있다. 제1밸브유로(511), 제2밸브유로(513)를 통해 압력생성부(400)로부터 압력을 가진 약액(D)이 유입될 수 있고, 이를 다시 니들 어셈블리(600)로 원활하게 공급할 수 있는 효과가 있다.The first valve passage 511 and the second valve passage 513 have a hollow interior and may be formed in a tube shape. Chemical liquid (D) with pressure can flow from the pressure generator 400 through the first valve passage 511 and the second valve passage 513, and can be smoothly supplied back to the needle assembly 600. It works.
도 8을 참조하면, 본 발명의 일 실시예에 따른 변형부(530)는 밸브본체(510)와 연결되는 것으로, 밸브본체(510)와 함께 약액(D) 수용 공간(DS)을 형성할 수 있다. Referring to FIG. 8, the deformable portion 530 according to an embodiment of the present invention is connected to the valve body 510, and can form a chemical liquid (D) receiving space (DS) together with the valve body 510. there is.
도 8을 참조하면, 약액(D) 수용 공간은 변형부(530)를 마주보는 밸브본체(510)의 일면과 변형부(530)의 내주면으로 둘러싸이는 내부 공간을 의미하는 것으로, 약액(D)이 수용될 수 있다.Referring to FIG. 8, the chemical liquid (D) accommodating space refers to an internal space surrounded by one side of the valve body 510 facing the deformable part 530 and the inner peripheral surface of the deformable part 530, and the chemical liquid (D) This can be accepted.
변형부(530)의 형상이 변형됨에 따라 약액(D) 수용 공간(DS)의 부피가 달라지게 되고, 약액(D) 수용 공간(DS)의 부피, 즉 약액(D)의 양이 미리 설정되는 양에 도달하면, 압력생성부(400)로부터 생성되는 압력에 의해 약액(D)이 제2밸브유로(513)를 통해 니들 어셈블리(600)로 공급될 수 있다.As the shape of the deformation part 530 is modified, the volume of the chemical liquid (D) receiving space (DS) changes, and the volume of the chemical liquid (D) receiving space (DS), that is, the amount of chemical liquid (D), is preset. When the amount is reached, the chemical solution (D) can be supplied to the needle assembly 600 through the second valve passage 513 by the pressure generated from the pressure generator 400.
도 8을 참조하면, 본 발명의 일 실시예에 따른 약액(D) 수용 공간(DS)에서 수용 가능한 부피(V)는 다음과 같은 과정을 통해서 도출될 수 있다.Referring to FIG. 8, the volume (V) that can be accommodated in the chemical solution (D) accommodation space (DS) according to an embodiment of the present invention can be derived through the following process.
도 8을 참조하면, 변형부(530)의 반지름이 a일 때, 변형부(530)의 중심에서의 거리가 r인 위치에서의 변형에 따른 변형부(530)의 높이 변화 w(r)와 관성 모멘트 D는 다음과 같다.Referring to FIG. 8, when the radius of the deformed part 530 is a, the height change w(r) of the deformed part 530 due to deformation at a position where the distance from the center of the deformed part 530 is r, and The moment of inertia D is as follows:
Figure PCTKR2023005059-appb-img-000001
Figure PCTKR2023005059-appb-img-000001
약액(D) 수용 공간(DS)의 부피(V)는 다음과 같다.The volume (V) of the chemical solution (D) receiving space (DS) is as follows.
Figure PCTKR2023005059-appb-img-000002
Figure PCTKR2023005059-appb-img-000002
Figure PCTKR2023005059-appb-img-000003
Figure PCTKR2023005059-appb-img-000003
Figure PCTKR2023005059-appb-img-000004
Figure PCTKR2023005059-appb-img-000004
최종적으로 약액(D) 수용 공간(DS)에서 수용 가능한 약액(D)의 부피(V)는 아래와 같다.Finally, the volume (V) of the chemical solution (D) that can be accommodated in the chemical solution (D) receiving space (DS) is as follows.
Figure PCTKR2023005059-appb-img-000005
Figure PCTKR2023005059-appb-img-000005
위의 식들에서 E는 탄성 계수(elastic modulus), v는 푸아송 비(poisson ratio), h는 변형부(530)의 두께, r는 변형부(530)의 중심으로부터의 거리, P는 압력생성부(400)로부터 전달받아 밸브부(500), 구체적으로 변형부(530)에 가해지는 압력, a는 변형부(530)의 반지름을 의미한다. In the above equations, E is the elastic modulus, v is the Poisson ratio, h is the thickness of the deformed part 530, r is the distance from the center of the deformed part 530, and P is pressure generation. The pressure received from the unit 400 and applied to the valve unit 500, specifically the deformable part 530, a denotes the radius of the deformed part 530.
도 10을 참조하면, 약액(D) 수용 공간(DS)에서 약액(D)의 부피는 압력생성부(400)로부터 전달받은 압력에 관한 함수로 정의될 수 있고, 미리 설정되는 부피에 도달하면 변형부(530)가 밸브본체(510) 측으로 이동하도록 형상이 변형됨으로 인하여 약액(D)을 니들 어셈블리(600)에 효과적으로 전달할 수 있다.Referring to FIG. 10, the volume of the chemical liquid (D) in the chemical liquid (D) receiving space (DS) may be defined as a function of the pressure transmitted from the pressure generator 400, and is deformed when a preset volume is reached. Because the shape of the portion 530 is modified to move toward the valve body 510, the chemical solution D can be effectively delivered to the needle assembly 600.
다시 말하여 약액 주입 장치(10)를 통해 사용자의 체내에 미리 설정되는 주기와 정량의 약액(D)이 주입되어야 하는데, 압력생성부(400)에 의해 생성되는 압력에 의해 밸브부(500) 내 약액(D) 수용 공간(DS)에 수용되는 약액(D)의 양이 미리 설정되는 양에 도달하는 경우 니들 어셈블리(600)를 통해 사용자의 체내에 안정적이고, 반복적으로 약액(D)이 전달될 수 있는 효과가 있다. In other words, the chemical solution (D) at a preset cycle and a fixed amount must be injected into the user's body through the chemical injection device 10, and the pressure generated by the pressure generator 400 is used to inject the drug solution (D) into the user's body. When the amount of the drug solution (D) accommodated in the drug solution (D) receiving space (DS) reaches a preset amount, the drug solution (D) will be stably and repeatedly delivered to the user's body through the needle assembly 600. There is a possible effect.
도 3을 참조하면, 본 발명의 일 실시예에 따른 니들 어셈블리(600)는 압력생성부(400)로부터 약액(D)을 공급받아 외부로 배출가능한 것으로, 캐뉼라(CN), 니들부(ND), 샤프트부(610), 삽입부(630), 추출부를 포함할 수 있다.Referring to FIG. 3, the needle assembly 600 according to an embodiment of the present invention is capable of receiving the chemical solution (D) from the pressure generating unit 400 and discharging it to the outside, and includes a cannula (CN) and a needle unit (ND). , may include a shaft portion 610, an insertion portion 630, and an extraction portion.
니들 어셈블리(600)는 밸브부(500)로부터 전달받은 약액(D)의 유동 경로를 제공하는 것으로, 캐뉼라(CN)의 내부에 위치하는 니들부(ND)가 사용자의 신체(HB)에 접촉하여 체내로 약액(D)을 주입할 수 있다.The needle assembly 600 provides a flow path for the chemical solution (D) delivered from the valve unit 500, and the needle unit (ND) located inside the cannula (CN) contacts the user's body (HB). The chemical solution (D) can be injected into the body.
도 3을 참조하면, 삽입부(630), 추출부는 샤프트부(610)의 길이 방향 중심축을 기준으로 상대 회전이 가능하며, 이들의 상대 회전에 의하여 캐뉼라(CN) 및 니들부(ND)가 사용자의 신체에 접촉, 삽입(insertion)되거나, 사용이 완료된 다음에 추출(retraction)될 수 있다.Referring to FIG. 3, the insertion unit 630 and the extraction unit can be relatively rotated based on the longitudinal central axis of the shaft unit 610, and the cannula (CN) and needle unit (ND) can be rotated relative to the user by their relative rotation. It can be contacted or inserted into the body, or extracted after use has been completed.
도 3을 참조하면, 삽입부(630)는 제1방향으로 탄성복원력을 가지는 제1탄성부재(631)를 포함하고, 추출부는 샤프트부(610)의 길이 방향 중심축을 기준으로 상기 제1방향과 반대 방향인 제2방향으로 탄성복원력을 가지는 제2탄성부재(651)를 포함할 수 있다.Referring to FIG. 3, the insertion portion 630 includes a first elastic member 631 having an elastic restoring force in a first direction, and the extraction portion is aligned in the first direction with respect to the longitudinal central axis of the shaft portion 610. It may include a second elastic member 651 having elastic restoring force in a second direction, which is the opposite direction.
제1탄성부재(631), 제2탄성부재(651)의 탄성복원력에 의하여 삽입부(630), 추출부가 상대 회전하며 니들부(ND)의 이동을 신속하게 할 수 있고, 약액 주입 장치(10)의 사용을 시작하기 전에 캐뉼라(CN) 및 니들부(ND)의 내부에 있는 공기를 외부로 배출하는 프라이밍(priming) 단계를 거쳐 사용자의 체내에 약액(D)을 바로 주입할 수 있는 효과가 있다.Due to the elastic restoring force of the first elastic member 631 and the second elastic member 651, the insertion part 630 and the extraction part rotate relative to each other and the needle part ND can be moved quickly, and the chemical injection device 10 ) Before starting use, a priming step is taken to exhaust the air inside the cannula (CN) and needle part (ND) to the outside, which has the effect of injecting the drug solution (D) directly into the user's body. there is.
도 9를 참조하면, 본 발명의 일 실시예에 따른 전원부(700)는 전원을 발생시키는 것으로, 압력생성부(400)와 전기적으로 연결될 수 있다. 구체적으로 전원부(700)에서 전원을 발생시켜 전극부(430)에 전원을 인가할 수 있고, 이로 인하여 전기장(EF)이 형성될 수 있다.Referring to FIG. 9, the power supply unit 700 according to an embodiment of the present invention generates power and may be electrically connected to the pressure generating unit 400. Specifically, the power supply unit 700 may generate power and apply power to the electrode unit 430, thereby forming an electric field EF.
압력생성본체(410)에 형성되는 제1유로부(414)의 양측에 배치되는 전극부(430), 구체적으로 제1전극(430a), 제2전극(430b) 사이에 전기장(EF)이 형성됨으로 인하여 유체가 미리 설정되는 방향으로 유동하며, 압력을 생성할 수 있고, 이러한 압력 생성과정이 제1유로부(414), 제2유로부(415), 전극부(430)로 형성되는 단일 단계를 복수 회 거치게 되면서 압력생성부(400)에서 목표로 하는 압력을 생성할 수 있는 효과가 있다.An electric field (EF) is formed between the electrode portions 430 disposed on both sides of the first flow path portion 414 formed in the pressure generating body 410, specifically the first electrode 430a and the second electrode 430b. Due to this, the fluid can flow in a preset direction and generate pressure, and this pressure generation process is a single step formed by the first flow path portion 414, the second flow path portion 415, and the electrode portion 430. There is an effect of generating a target pressure in the pressure generator 400 by going through the process multiple times.
도면에 도시하지는 않았지만, 전원부(700)는 뒤에 설명할 센서부(810)와 전기적으로 연결되며, 센서부(810)에 전원을 공급할 수 있다. Although not shown in the drawing, the power supply unit 700 is electrically connected to the sensor unit 810, which will be described later, and can supply power to the sensor unit 810.
도 9를 참조하면, 본 발명의 일 실시예에 따른 센서부(810)는, 밸브부(500)와 연결되는 것으로, 밸브부(500)로 유입되는 약액(D)의 유량을 센싱할 수 있다. 센서부(810)는 약액(D)의 유량에 관한 정보를 전기적 신호로 제어부(850)에 전달할 수 있고, 제어부(850)는 압력생성부(400)의 구동을 제어할 수 있다. Referring to FIG. 9, the sensor unit 810 according to an embodiment of the present invention is connected to the valve unit 500 and can sense the flow rate of the chemical solution (D) flowing into the valve unit 500. . The sensor unit 810 can transmit information about the flow rate of the chemical solution (D) to the control unit 850 as an electrical signal, and the control unit 850 can control the operation of the pressure generator 400.
즉, 목표로 하는 밸브부(500)의 약액(D) 수용 공간(DS)의 부피에 도달할 수 있도록 요구되는 압력을 생성할 수 있도록, 제어부(850)는 압력생성부(400)에 전기적 신호를 전달하여 압력생성부(400)의 구동을 제어할 수 있는 효과가 있다.That is, the control unit 850 sends an electrical signal to the pressure generator 400 to generate the required pressure to reach the target volume of the chemical solution (D) receiving space (DS) of the valve unit 500. There is an effect of controlling the operation of the pressure generator 400 by transmitting.
본 발명의 일 실시예에 따른 약액 주입 장치는, 압력생성부가 전압을 인가받아 유체의 유동에 의한 압력을 생성하고, 니들 어셈블리에 약액이 안정적으로 공급될 수 있어, 사용자에게 편의를 제공할 수 있는 효과가 있다.In the chemical injection device according to an embodiment of the present invention, the pressure generator receives voltage and generates pressure by the flow of fluid, and the chemical liquid can be stably supplied to the needle assembly, providing convenience to the user. It works.
또한, 형상 변형이 가능한 밸브부로 인하여, 미리 설정되는 양만큼 약액이 니들 어셈블리로 공급됨으로 인하여, 사용자에게 주입되는 약액의 양을 정밀하게 제어할 수 있는 효과가 있다.In addition, due to the valve part capable of changing shape, a preset amount of chemical solution is supplied to the needle assembly, which has the effect of precisely controlling the amount of chemical solution injected into the user.
본 발명의 사상은 상기 설명된 실시예에 국한되어 정해져서는 아니되며, 후술하는 특허청구범위뿐만 아니라, 이 특허청구범위와 균등한 또는 이로부터 등가적으로 변경된 모든 범위는 본 발명의 사상의 범주에 속한다고 할 것이다.The spirit of the present invention should not be limited to the above-described embodiments, and the scope of the claims described below, as well as all scopes equivalent to or equivalently changed from the claims, are within the scope of the spirit of the present invention. It will be said that it belongs.
본 발명에 의하면, 약액 주입 장치를 제공한다. 또한, 산업상 이용하는, 환자의 몸 안에 약액을 주입하는 기구 등에 본 발명의 실시예들을 적용할 수 있다.According to the present invention, a chemical liquid injection device is provided. Additionally, embodiments of the present invention can be applied to industrial devices that inject medicinal solutions into a patient's body.

Claims (7)

  1. 약액이 수용되는 레저버 유닛;A reservoir unit containing a chemical solution;
    상기 레저버 유닛과 연결되고, 상기 레저버 유닛으로부터 공급되는 약액의 유동 경로를 제공하는 압력생성부; 및a pressure generator connected to the reservoir unit and providing a flow path for the chemical solution supplied from the reservoir unit; and
    상기 압력생성부로부터 약액을 공급받아 외부로 배출가능한 니들 어셈블리;를 포함하고,It includes a needle assembly capable of receiving the chemical solution from the pressure generator and discharging it to the outside,
    상기 압력생성부는, 미리 설정되는 방향을 따라 약액이 유동하는 동안 상기 약액의 압력을 증가시키는 것을 특징으로 하는 약액 주입 장치.The pressure generator is a chemical injection device characterized in that it increases the pressure of the chemical liquid while it flows along a preset direction.
  2. 제1항에 있어서,According to paragraph 1,
    상기 압력생성부와 상기 니들 어셈블리 사이에 배치되며, 미리 설정되는 양만큼 약액을 상기 니들 어셈블리로 공급하는 밸브부;를 더 포함하는 것을 특징으로 하는 약액 주입 장치.A valve portion disposed between the pressure generator and the needle assembly and supplying a preset amount of the chemical solution to the needle assembly.
  3. 제2항에 있어서,According to paragraph 2,
    상기 밸브부와 연결되고, 상기 밸브부로 유입되는 약액의 유량을 센싱하는 센서부;를 더 포함하는 것을 특징으로 하는 약액 주입 장치.A sensor unit connected to the valve unit and configured to sense the flow rate of the chemical liquid flowing into the valve unit.
  4. 제3항에 있어서,According to paragraph 3,
    상기 센서부와 전기적으로 연결되고, 상기 센서부로부터 약액의 유량에 관한 정보를 전달받아 상기 압력생성부의 구동을 제어하는 제어부;를 더 포함하는 것을 특징으로 하는 약액 주입 장치.A control unit electrically connected to the sensor unit and receiving information about the flow rate of the chemical solution from the sensor unit to control the operation of the pressure generator.
  5. 제1항에 있어서,According to paragraph 1,
    상기 압력생성부와 전기적으로 연결되고, 상기 압력생성부로 전원을 공급하여 전기장을 형성하는 전원부;를 더 포함하는 것을 특징으로 하는 약액 주입 장치.A power supply unit electrically connected to the pressure generator and supplying power to the pressure generator to form an electric field.
  6. 제1항에 있어서,According to paragraph 1,
    상기 레저버 유닛, 상기 압력생성부 및 상기 니들 어셈블리가 설치되는 베이스부;를 더 포함하는 것을 특징으로 하는 약액 주입 장치.A chemical injection device further comprising a base portion on which the reservoir unit, the pressure generating portion, and the needle assembly are installed.
  7. 제6항에 있어서,According to clause 6,
    상기 니들 어셈블리는, 상기 베이스부를 관통하여 외부에 노출되는 니들부;를 포함하는 것을 특징으로 하는 약액 주입 장치.The needle assembly includes a needle portion that penetrates the base portion and is exposed to the outside.
PCT/KR2023/005059 2022-04-15 2023-04-14 Medicinal liquid injection device WO2023200286A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237021654A KR20230148323A (en) 2022-04-15 2023-04-14 chemical injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263363088P 2022-04-15 2022-04-15
US63/363,088 2022-04-15

Publications (1)

Publication Number Publication Date
WO2023200286A1 true WO2023200286A1 (en) 2023-10-19

Family

ID=88330041

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2023/005059 WO2023200286A1 (en) 2022-04-15 2023-04-14 Medicinal liquid injection device

Country Status (2)

Country Link
KR (1) KR20230148323A (en)
WO (1) WO2023200286A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092865A1 (en) * 2001-11-09 2004-05-13 J. Christopher Flaherty Transcutaneous delivery means
KR20140101255A (en) * 2013-02-08 2014-08-19 서현배 Patch type infusion pump
KR101476042B1 (en) * 2013-07-09 2014-12-23 김용무 Regulator for injecting medical liguid and medical liquid injection apparatus comprising the same
KR101928297B1 (en) * 2016-09-08 2018-12-12 이오플로우(주) Medical fluid delivery device
JP2019080916A (en) * 2017-10-27 2019-05-30 研能科技股▲ふん▼有限公司 Liquid supply device for human insulin injection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092865A1 (en) * 2001-11-09 2004-05-13 J. Christopher Flaherty Transcutaneous delivery means
KR20140101255A (en) * 2013-02-08 2014-08-19 서현배 Patch type infusion pump
KR101476042B1 (en) * 2013-07-09 2014-12-23 김용무 Regulator for injecting medical liguid and medical liquid injection apparatus comprising the same
KR101928297B1 (en) * 2016-09-08 2018-12-12 이오플로우(주) Medical fluid delivery device
JP2019080916A (en) * 2017-10-27 2019-05-30 研能科技股▲ふん▼有限公司 Liquid supply device for human insulin injection

Also Published As

Publication number Publication date
KR20230148323A (en) 2023-10-24

Similar Documents

Publication Publication Date Title
WO2018048100A1 (en) Liquid medicine injection device
EP3247268A1 (en) Sensor module and wearable body compositon analyzer including same
WO2015002492A1 (en) Medication tracker
WO2019156493A1 (en) Electronic device including detachable measurement module and attachment pad
WO2016144021A1 (en) Wearable device having low-frequency generation function, and healthcare system using same
WO2018124809A1 (en) Wearable terminal and method for operating same
WO2022039532A1 (en) Medication adherence monitoring system and device using same
WO2016165667A1 (en) Warning method utilizing motion-sensing control device for preventing loss of smart electronic device
WO2020027427A1 (en) Continuous blood glucose measurement apparatus
WO2023200286A1 (en) Medicinal liquid injection device
WO2020045693A1 (en) Dose setting knob-mounted general-purpose input quantity measurement and management system for pen type injection device
WO2020027426A1 (en) Body attachment unit for continuous glucose monitoring
WO2019009638A1 (en) General-purpose mounting-type input amount measurement and management system of pen type syringe device
WO2022173103A1 (en) Wearable device for measuring multiple biosignals, and artificial-intelligence-based remote monitoring system using same
WO2018124463A2 (en) Universal mounting type dosage measurement and management system for pen-type injection device
WO2023106692A1 (en) Drug compliance management system
WO2022071656A1 (en) Drug injection device
WO2022182030A1 (en) Pump
WO2022186548A1 (en) Driving control mechanism and drug injection apparatus using same
WO2021010569A1 (en) Near field communication connection method of continuous glucose monitoring system
WO2021020688A1 (en) Method for stabilizing continuous glucose monitoring system
WO2022059944A1 (en) Needle assembly, and liquid medicine injection apparatus comprising same
WO2022050451A1 (en) Wirelessly-powered smart contact lens for intraocular pressure measurement and treatment of glaucoma patient
WO2020184819A1 (en) Liquid chemical ejection assembly and liquid chemical injection device including same
WO2021125617A2 (en) Liquid medicine injection device having driving time symmetrization algorithm applied thereto, driving time symmetrization method, and recording medium thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23788635

Country of ref document: EP

Kind code of ref document: A1